Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED SCHEDULE OF INVESTMENTS

v3.22.4
CONSOLIDATED SCHEDULE OF INVESTMENTS
£ in Thousands, $ in Thousands
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2022
GBP (£)
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
GBP (£)
shares
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 7.50% 7.50%    
Investment cost $ 3,005,696   $ 2,390,984  
Total investments at fair value 2,963,955   2,434,522  
Investment Funds & Vehicles [Member]        
Investment Holdings [Line Items]        
Investment cost [1]     2,032  
Total investments at fair value 3,893   1,814  
Senior Secured Debt        
Investment Holdings [Line Items]        
Total investments at fair value 2,741,388   2,156,709  
Unsecured        
Investment Holdings [Line Items]        
Total investments at fair value 54,056   52,890  
Debt Investments        
Investment Holdings [Line Items]        
Investment cost 2,818,060 [2]   2,219,586 [1]  
Total investments at fair value 2,795,444   2,209,599  
Equity        
Investment Holdings [Line Items]        
Investment cost 153,173 [2]   142,219  
Total investments at fair value 133,972   184,710  
Equity | Preferred Stock        
Investment Holdings [Line Items]        
Total investments at fair value 41,488   69,439  
Equity | Common Stock        
Investment Holdings [Line Items]        
Total investments at fair value 92,484   115,271  
Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 30,964 [2]   27,147 [1]  
Total investments at fair value 30,646   38,399  
Investments in Securities        
Investment Holdings [Line Items]        
Investment cost 3,002,197 [2]   2,388,952 [1]  
Total investments at fair value 2,960,062   2,432,708  
Investment        
Investment Holdings [Line Items]        
Investment cost 3,005,696 [2]   2,390,984 [1]  
Total investments at fair value 2,963,955   2,434,522  
Forbion Growth Opportunities Fund I C V | Investment Funds & Vehicles [Member]        
Investment Holdings [Line Items]        
Investment cost [1],[3],[4],[5]     2,032  
Total investments at fair value [3],[4],[5]     $ 1,814  
Acquisition Date [6]     Nov. 16, 2020 Nov. 16, 2020
Black Crow AI, Inc. affiliates        
Investment Holdings [Line Items]        
Principal Amount     $ 3,000  
Medrobotics Corporation [Member] | Warrant Investment | Preferred Series E        
Investment Holdings [Line Items]        
Acquisition Date [6]     Mar. 13, 2013 Mar. 13, 2013
Biotechnology Tools        
Investment Holdings [Line Items]        
Total investments at fair value 32,825   $ 0  
Biotechnology Tools | Debt Investments        
Investment Holdings [Line Items]        
Investment cost [2] 32,339      
Total investments at fair value 32,339      
Biotechnology Tools | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [2] 485      
Total investments at fair value $ 486      
Biotechnology Tools | Alamar Biosciences, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-06 2026-06    
Investment Interest Rate Floor [7] 6.50% 6.50%    
Investment Interest Rate Paid in Kind [7] 1.00% 1.00%    
Principal Amount [8] $ 5,000      
Investment cost [2],[8] 4,951      
Total investments at fair value [8] $ 4,951      
Biotechnology Tools | Alamar Biosciences, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 5.95% 5.95%    
Biotechnology Tools | Alamar Biosciences, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.00% 3.00%    
Biotechnology Tools | Alamar Biosciences, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [2] $ 24      
Total investments at fair value $ 23      
Acquisition Date [9] Jun. 21, 2022 Jun. 21, 2022    
Shares | shares 15,399 15,399    
Biotechnology Tools | PathAI, Inc | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-01 2027-01    
Investment Interest Rate Floor [7] 9.15% 9.15%    
Principal Amount [8] $ 28,000      
Investment cost [2],[8] 27,388      
Total investments at fair value [8] $ 27,388      
Biotechnology Tools | PathAI, Inc | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 11.21% 11.21%    
Biotechnology Tools | PathAI, Inc | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 2.15% 2.15%    
Biotechnology Tools | PathAI, Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 461      
Total investments at fair value $ 463      
Acquisition Date [9] Dec. 23, 2022 Dec. 23, 2022    
Shares | shares 53,418 53,418    
Communications & Networking        
Investment Holdings [Line Items]        
Total investments at fair value $ 101,833   105,490  
Communications & Networking | Debt Investments        
Investment Holdings [Line Items]        
Investment cost 99,167 [2]   97,088 [1]  
Total investments at fair value 101,734   99,230  
Communications & Networking | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     1,230  
Total investments at fair value     6,260  
Communications & Networking | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 541 [2]   418  
Total investments at fair value $ 99   $ 0  
Communications & Networking | Aryaka Networks, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-07 2026-07    
Investment Interest Rate Floor [7] 6.75% 6.75%    
Investment Interest Rate Paid in Kind [7] 1.05% 1.05%    
Principal Amount [8],[10],[11] $ 5,023      
Investment cost [2],[8],[10],[11] 4,969      
Total investments at fair value [8],[10],[11] $ 5,053      
Communications & Networking | Aryaka Networks, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.55% 3.55%    
Communications & Networking | Aryaka Networks, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.25% 3.25%    
Communications & Networking | Aryaka Networks, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 123      
Total investments at fair value $ 99      
Acquisition Date [9] Jun. 28, 2022 Jun. 28, 2022    
Shares | shares 229,611 229,611    
Communications & Networking | Cytracom Holdings LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-02 2025-02 2025-02 2025-02
Investment Interest Rate Floor 10.31% [7] 10.31% [7] 10.31% [12] 10.31% [12]
Principal Amount $ 8,910 [8],[13],[14]   $ 9,000 [3],[15],[16]  
Investment cost 8,768 [2],[8],[13],[14]   8,802 [1],[3],[15],[16]  
Total investments at fair value $ 8,748 [8],[13],[14]   $ 8,725 [3],[15],[16]  
Communications & Networking | Cytracom Holdings LLC | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 9.31% [7] 9.31% [7] 9.31% [12] 9.31% [12]
Communications & Networking | Spring Mobile Solutions, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 418 [2]   $ 418  
Total investments at fair value   $ 0  
Acquisition Date Apr. 19, 2013 [9] Apr. 19, 2013 [9] Apr. 19, 2013 [6] Apr. 19, 2013 [6]
Shares | shares 2,834,375 2,834,375 2,834,375 2,834,375
Communications & Networking | Rocket Lab Global Services, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-06 2024-06 2024-06 2024-06
Investment Interest Rate Floor 8.15% [7] 8.15% [7] 8.15% [12] 8.15% [12]
Investment Interest Rate Paid in Kind 1.25% [7] 1.25% [7] 1.25% [12] 1.25% [12]
Principal Amount $ 84,581 [11],[13],[17],[18],[19]   $ 88,542 [20],[21]  
Investment cost 85,430 [2],[11],[13],[17],[18],[19]   88,286 [1],[20],[21]  
Total investments at fair value $ 87,933 [11],[13],[17],[18],[19]   $ 90,505 [20],[21]  
Communications & Networking | Rocket Lab Global Services, LLC | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 3.25% [7] 3.25% [7] 3.25% [12] 3.25% [12]
Communications & Networking | Rocket Lab Global Services, LLC | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 4.90% [7] 4.90% [7] 4.90% [12] 4.90% [12]
Communications & Networking | Peerless Network Holdings, Inc. | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     $ 1,230  
Total investments at fair value     $ 6,260  
Shares | shares     1,138,328 1,138,328
Communications & Networking | Peerless Network Holdings, Inc. | Equity | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [1]     $ 1,230  
Total investments at fair value     $ 6,242  
Acquisition Date [6]     Apr. 11, 2008 Apr. 11, 2008
Shares | shares     1,135,000 1,135,000
Communications & Networking | Peerless Network Holdings, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 0  
Total investments at fair value     $ 18  
Acquisition Date [6]     Oct. 21, 2020 Oct. 21, 2020
Shares | shares     3,328 3,328
Consumer & Business Products        
Investment Holdings [Line Items]        
Total investments at fair value $ 2,821   $ 28,099  
Consumer & Business Products | Debt Investments        
Investment Holdings [Line Items]        
Investment cost [1]     23,162  
Total investments at fair value     23,298  
Consumer & Business Products | Equity        
Investment Holdings [Line Items]        
Investment cost 663 [2]   128 [1]  
Total investments at fair value 498   447  
Consumer & Business Products | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 1,712 [2]   2,145 [1]  
Total investments at fair value 2,323   4,354  
Consumer & Business Products | TechStyle, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [2] 1,101      
Total investments at fair value $ 745      
Acquisition Date [9] Jul. 16, 2013 Jul. 16, 2013    
Shares | shares 206,185 206,185    
Consumer & Business Products | Whoop, Inc. | Warrant Investment | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost $ 18 [2]   18 [1]  
Total investments at fair value $ 475   $ 1,847  
Acquisition Date Jun. 27, 2018 [9] Jun. 27, 2018 [9] Jun. 27, 2018 [6] Jun. 27, 2018 [6]
Shares | shares 686,270 686,270 686,270 686,270
Consumer & Business Products | The Neat Company | Common Stock | Preferred Series C        
Investment Holdings [Line Items]        
Total investments at fair value     $ 0  
Consumer & Business Products | The Neat Company | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 365 [2]   $ 365 [1]  
Total investments at fair value      
Acquisition Date Aug. 13, 2014 [9] Aug. 13, 2014 [9] Aug. 13, 2014 [6] Aug. 13, 2014 [6]
Shares | shares 54,054 54,054 54,054 54,054
Consumer & Business Products | Grove Collaborative, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2025-04 2025-04
Investment Interest Rate Floor [12]     8.75% 8.75%
Principal Amount [22]     $ 23,520  
Investment cost [1],[22]     23,162  
Total investments at fair value [22]     $ 23,298  
Consumer & Business Products | Grove Collaborative, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     6.75% 6.75%
Consumer & Business Products | Grove Collaborative, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.50% 5.50%
Consumer & Business Products | Grove Collaborative, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 433      
Total investments at fair value [9] $ 24      
Acquisition Date [9] Apr. 30, 2021 Apr. 30, 2021    
Shares | shares [9] 61,300 61,300    
Consumer & Business Products | Grove Collaborative, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 433  
Total investments at fair value     $ 326  
Acquisition Date [6]     Apr. 30, 2021 Apr. 30, 2021
Shares | shares     83,625 83,625
Consumer & Business Products | Penumbra Brands, LLC (p.k.a. Gadget Guard) | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 228  
Total investments at fair value     $ 0  
Acquisition Date [6]     Jun. 03, 2014 Jun. 03, 2014
Shares | shares     1,662,441 1,662,441
Consumer & Business Products | TFG Holding, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 89      
Total investments at fair value $ 116      
Acquisition Date [9] Apr. 30, 2010 Apr. 30, 2010    
Shares | shares 42,989 42,989    
Consumer & Business Products | TFG Holding, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 0      
Total investments at fair value      
Acquisition Date [9] Jun. 27, 2014 Jun. 27, 2014    
Shares | shares 206,185 206,185    
Consumer & Business Products | Savage X Holding, LLC | Equity | Class A Units        
Investment Holdings [Line Items]        
Investment cost [2] $ 13      
Total investments at fair value $ 226      
Acquisition Date [9] Apr. 30, 2010 Apr. 30, 2010    
Shares | shares 42,137 42,137    
Consumer & Business Products | Savage X Holding, LLC | Warrant Investment | Class A Units        
Investment Holdings [Line Items]        
Investment cost [2] $ 0      
Total investments at fair value $ 1,103      
Acquisition Date [9] Jun. 27, 2014 Jun. 27, 2014    
Shares | shares 206,185 206,185    
Consumer & Business Products | TechStyle, Inc. (p.k.a. Just Fabulous, Inc.) | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 128 [2]   $ 128 [1]  
Total investments at fair value $ 132   $ 447  
Acquisition Date Apr. 30, 2010 [9] Apr. 30, 2010 [9] Apr. 30, 2010 [6] Apr. 30, 2010 [6]
Shares | shares 42,989 42,989 42,989 42,989
Consumer & Business Products | TechStyle, Inc. (p.k.a. Just Fabulous, Inc.) | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [1]     $ 1,101  
Total investments at fair value     $ 2,181  
Acquisition Date [6]     Jul. 16, 2013 Jul. 16, 2013
Shares | shares     206,185 206,185
Consumer & Business Products | Gadget Guard, LLC | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 228      
Total investments at fair value      
Acquisition Date [9] Jun. 03, 2014 Jun. 03, 2014    
Shares | shares 1,662,441 1,662,441    
Consumer & Business Services | Debt Investments        
Investment Holdings [Line Items]        
Investment cost [2] $ 444,703      
Total investments at fair value 428,750      
Consumer & Business Services | Equity        
Investment Holdings [Line Items]        
Investment cost [2] 13,488      
Total investments at fair value 7,995      
Consumer & Business Services | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [2] 4,248      
Total investments at fair value $ 2,639      
Consumer & Business Services | Jobandtalent USA, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-02 2025-02    
Investment Interest Rate Floor [7] 9.75% 9.75%    
Principal Amount [23],[24] $ 14,000      
Investment cost [2],[23],[24] 13,853      
Total investments at fair value [23],[24] $ 13,904      
Consumer & Business Services | Jobandtalent USA, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.00% 3.00%    
Consumer & Business Services | Jobandtalent USA, Inc. | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.86% 8.86%    
Consumer & Business Services | Provi | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-12 2026-12    
Investment Interest Rate Floor [7] 10.65% 10.65%    
Principal Amount [25] $ 15,000      
Investment cost [2],[25] 14,739      
Total investments at fair value [25] $ 14,739      
Consumer & Business Services | Provi | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 2.95% 2.95%    
Consumer & Business Services | Provi | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.40% 4.40%    
Consumer & Business Services | Provi | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[25] $ 166      
Total investments at fair value [25] $ 155      
Acquisition Date [9] Dec. 22, 2022 Dec. 22, 2022    
Shares | shares [25] 117,042 117,042    
Consumer & Business Services | Veem, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-03 2025-03    
Investment Interest Rate Floor [7] 7.25% 7.25%    
Investment Interest Rate Paid in Kind [7] 1.25% 1.25%    
Principal Amount [11],[17] $ 5,043      
Investment cost [2],[11],[17] 5,000      
Total investments at fair value [11],[17] $ 5,042      
Consumer & Business Services | Veem, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.50% 4.50%    
Consumer & Business Services | Veem, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.00% 4.00%    
Consumer & Business Services | Veem, Inc. | Debt Investments        
Investment Holdings [Line Items]        
Principal Amount $ 10,076      
Investment cost [2] 9,988      
Total investments at fair value 10,166      
Consumer & Business Services | Veem, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] 126      
Total investments at fair value $ 25      
Acquisition Date [9] Mar. 31, 2022 Mar. 31, 2022    
Shares | shares 98,428 98,428    
Consumer & Business Services | Veem, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-03 2025-03    
Investment Interest Rate Floor [7] 7.95% 7.95%    
Investment Interest Rate Paid in Kind [7] 1.50% 1.50%    
Principal Amount [11] $ 5,033      
Investment cost [2],[11] 4,988      
Total investments at fair value [11] $ 5,124      
Consumer & Business Services | Veem, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.50% 4.50%    
Consumer & Business Services | Veem, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.70% 4.70%    
Consumer & Business Services | RVShare, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-12 2026-12    
Investment Interest Rate Floor [7] 6.50% 6.50%    
Investment Interest Rate Paid in Kind [7] 4.00% 4.00%    
Principal Amount [8],[11],[17],[25] $ 27,730      
Investment cost [2],[8],[11],[17],[25] 27,265      
Total investments at fair value [8],[11],[17],[25] $ 27,256      
Consumer & Business Services | RVShare, LLC | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.50% 5.50%    
Consumer & Business Services | Snagajobcom Inc | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [2] $ 860      
Total investments at fair value $ 118      
Shares | shares 3,611,537 3,611,537    
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [2] $ 782      
Total investments at fair value $ 50      
Acquisition Date [9] Jun. 30, 2016 Jun. 30, 2016    
Shares | shares 1,800,000 1,800,000    
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [2] $ 62      
Total investments at fair value $ 25      
Acquisition Date [9] Aug. 01, 2018 Aug. 01, 2018    
Shares | shares 1,211,537 1,211,537    
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 16      
Total investments at fair value $ 43      
Acquisition Date [9] Apr. 20, 2020 Apr. 20, 2020    
Shares | shares 600,000 600,000    
Consumer & Business Services | RumbleON, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 88      
Total investments at fair value [9] $ 0      
Acquisition Date [9] Apr. 30, 2018 Apr. 30, 2018    
Shares | shares [9] 5,139 5,139    
Consumer & Business Services | Lendio, Inc. | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [2] $ 39      
Total investments at fair value $ 19      
Acquisition Date [9] Mar. 29, 2019 Mar. 29, 2019    
Shares | shares 127,032 127,032    
Consumer & Business Services | Landing Holdings Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[25] $ 116      
Total investments at fair value [25] $ 127      
Acquisition Date [9] Mar. 12, 2021 Mar. 12, 2021    
Shares | shares [25] 11,806 11,806    
Consumer & Business Services | Lyft Inc | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 5,263      
Total investments at fair value [9] $ 1,110      
Acquisition Date [9] Dec. 26, 2018 Dec. 26, 2018    
Shares | shares [9] 100,738 100,738    
Consumer & Business Services | Uber Technologies, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 318      
Total investments at fair value [9] $ 816      
Acquisition Date [9] Dec. 01, 2020 Dec. 01, 2020    
Shares | shares [9] 32,991 32,991    
Consumer & Business Services | Nerdy Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 1,000      
Total investments at fair value [9] $ 225      
Acquisition Date [9] Sep. 17, 2021 Sep. 17, 2021    
Shares | shares [9] 100,000 100,000    
Consumer & Business Services | DoorDash, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 945      
Total investments at fair value [9] $ 4,003      
Acquisition Date [9] Dec. 20, 2018 Dec. 20, 2018    
Shares | shares [9] 81,996 81,996    
Consumer & Business Services | OfferUp, Inc. | Equity        
Investment Holdings [Line Items]        
Investment cost [2] $ 2,295      
Total investments at fair value $ 513      
Shares | shares 394,790 394,790    
Consumer & Business Services | OfferUp, Inc. | Equity | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [2] $ 1,663      
Total investments at fair value $ 372      
Acquisition Date [9] Oct. 25, 2016 Oct. 25, 2016    
Shares | shares 286,080 286,080    
Consumer & Business Services | OfferUp, Inc. | Equity | Preferred Series A-1        
Investment Holdings [Line Items]        
Investment cost [2] $ 632      
Total investments at fair value $ 141      
Acquisition Date [9] Oct. 25, 2016 Oct. 25, 2016    
Shares | shares 108,710 108,710    
Consumer & Business Services | Oportun | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 577      
Total investments at fair value [9] $ 266      
Acquisition Date [9] Jun. 28, 2013 Jun. 28, 2013    
Shares | shares [9] 48,365 48,365    
Consumer & Business Services | Reischling Press, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 39      
Total investments at fair value      
Acquisition Date [9] Jul. 31, 2020 Jul. 31, 2020    
Shares | shares 3,095 3,095    
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-04 2026-04    
Investment Interest Rate Floor [7] 8.75% 8.75%    
Principal Amount [8],[18] $ 40,790      
Investment cost [2],[8],[18] 41,856      
Total investments at fair value [8],[18] $ 42,426      
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 8.29% 8.29%    
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.50% 5.50%    
Consumer & Business Services | Carwow LTD | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-12 2024-12    
Investment Interest Rate Floor [7] 7.95% 7.95%    
Investment Interest Rate Paid in Kind [7] 1.45% 1.45%    
Principal Amount | £ [11],[23],[24]   £ 18,890    
Investment cost [2],[11],[23],[24] $ 26,024      
Total investments at fair value [11],[23],[24] $ 22,971      
Consumer & Business Services | Carwow LTD | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.95% 4.95%    
Consumer & Business Services | Carwow LTD | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.70% 4.70%    
Consumer & Business Services | Carwow LTD | Equity | Preferred Series D-4        
Investment Holdings [Line Items]        
Investment cost [2],[23],[24] $ 1,151      
Total investments at fair value [23],[24] $ 257      
Acquisition Date [9] Dec. 15, 2021 Dec. 15, 2021    
Shares | shares [23],[24] 199,742 199,742    
Consumer & Business Services | Carwow LTD | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[23],[24] $ 164      
Total investments at fair value [23],[24] $ 34      
Acquisition Date [9] Dec. 14, 2021 Dec. 14, 2021    
Shares | shares [23],[24] 174,163 174,163    
Consumer & Business Services | Houzz, Inc. | Convertible Debt        
Investment Holdings [Line Items]        
Maturity Date 2028-05 2028-05    
Investment Interest Rate Paid in Kind [7] 5.50% 5.50%    
Principal Amount [11],[26] $ 21,853      
Investment cost [2],[11],[26] 21,853      
Total investments at fair value [11],[26] 20,356      
Consumer & Business Services | Houzz, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] 20      
Total investments at fair value      
Acquisition Date [9] Oct. 29, 2019 Oct. 29, 2019    
Shares | shares 529,661 529,661    
Consumer & Business Services | Rhino Labs Incorporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-03 2024-03    
Investment Interest Rate Floor [7] 8.75% 8.75%    
Investment Interest Rate Paid in Kind [7] 2.25% 2.25%    
Principal Amount [11],[25] $ 16,500      
Investment cost [2],[11],[25] 16,328      
Total investments at fair value [11],[25] $ 16,496      
Consumer & Business Services | Rhino Labs Incorporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.50% 5.50%    
Consumer & Business Services | Rhino Labs Incorporation | Equity | Preferred Series B-2        
Investment Holdings [Line Items]        
Investment cost [2] $ 1,000      
Total investments at fair value $ 805      
Acquisition Date [9] Jan. 24, 2022 Jan. 24, 2022    
Shares | shares 7,063 7,063    
Consumer & Business Services | Rhino Labs Incorporation | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[25] $ 470      
Total investments at fair value [25] $ 308      
Acquisition Date [9] Mar. 12, 2021 Mar. 12, 2021    
Shares | shares [25] 13,106 13,106    
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2023-06 2023-06    
Investment Interest Rate Floor [7] 10.50% 10.50%    
Investment Interest Rate Paid in Kind [7] 0.50% 0.50%    
Principal Amount [11],[17],[18],[19] $ 60,915      
Investment cost [2],[11],[17],[18],[19] 60,721      
Total investments at fair value [11],[17],[18],[19] $ 60,721      
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.00% 5.00%    
Consumer & Business Services | SeatGeek, Inc. | Debt Investments        
Investment Holdings [Line Items]        
Principal Amount $ 85,986      
Investment cost [2] 85,633      
Total investments at fair value 86,544      
Consumer & Business Services | SeatGeek, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[18],[19] 842      
Total investments at fair value [18],[19] $ 1,332      
Acquisition Date [9] Jun. 12, 2019 Jun. 12, 2019    
Shares | shares [18],[19] 1,379,761 1,379,761    
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-05 2026-05    
Investment Interest Rate Floor [7] 10.50% 10.50%    
Investment Interest Rate Paid in Kind [7] 0.50% 0.50%    
Principal Amount [11],[13],[19] $ 25,071      
Investment cost [2],[11],[13],[19] 24,912      
Total investments at fair value [11],[13],[19] $ 25,823      
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 7.00% 7.00%    
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-11 2026-11    
Investment Interest Rate Floor [7] 9.25% 9.25%    
Investment Interest Rate Paid in Kind [7] 1.75% 1.75%    
Principal Amount [11],[17] $ 9,007      
Investment cost [2],[11],[17] 8,918      
Total investments at fair value [11],[17] $ 8,870      
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.00% 3.00%    
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 2.75% 2.75%    
Consumer & Business Services | Skyword, Inc. | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [2] $ 140      
Total investments at fair value $ 43      
Shares | shares 2,051,587 2,051,587    
Consumer & Business Services | Skyword, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [2] $ 83      
Total investments at fair value      
Acquisition Date [9] Aug. 23, 2019 Aug. 23, 2019    
Shares | shares 444,444 444,444    
Consumer & Business Services | Skyword, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 57      
Total investments at fair value $ 43      
Acquisition Date [9] Nov. 14, 2022 Nov. 14, 2022    
Shares | shares 1,607,143 1,607,143    
Consumer & Business Services | Tectura Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-07 2024-07    
Investment Interest Rate Paid in Kind [7] 5.00% 5.00%    
Principal Amount [11],[27],[28] $ 10,680      
Investment cost [2],[11],[27],[28] 240      
Total investments at fair value [11],[27],[28] 0      
Consumer & Business Services | Tectura Corporation | Debt Investments        
Investment Holdings [Line Items]        
Principal Amount 31,953      
Investment cost [2] 21,513      
Total investments at fair value $ 8,042      
Consumer & Business Services | Tectura Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-07 2024-07    
Principal Amount [11],[27],[28] $ 8,250      
Investment Interest Rate Paid in Cash [7] 8.25% 8.25%    
Investment cost [2],[11],[27],[28] $ 8,250      
Total investments at fair value [11],[27],[28] $ 8,042      
Consumer & Business Services | Tectura Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-07 2024-07    
Investment Interest Rate Paid in Kind [7] 5.00% 5.00%    
Principal Amount [11],[27],[28] $ 13,023      
Investment cost [2],[11],[27],[28] 13,023      
Total investments at fair value [11],[27],[28] 0      
Consumer & Business Services | Tectura Corporation | Equity        
Investment Holdings [Line Items]        
Investment cost [2] 900      
Total investments at fair value      
Shares | shares 415,994,863 415,994,863    
Consumer & Business Services | Tectura Corporation | Equity | Preferred Series BB        
Investment Holdings [Line Items]        
Investment cost [27] $ 0      
Total investments at fair value [27] $ 0      
Acquisition Date [9] Jun. 06, 2016 Jun. 06, 2016    
Shares | shares [27] 1,000,000 1,000,000    
Consumer & Business Services | Tectura Corporation | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[27] $ 900      
Total investments at fair value [27] $ 0      
Acquisition Date [9] May 23, 2018 May 23, 2018    
Shares | shares [27] 414,994,863 414,994,863    
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-04 2026-04    
Investment Interest Rate Floor [7] 8.20% 8.20%    
Investment Interest Rate Paid in Kind [7] 1.50% 1.50%    
Principal Amount [8],[11],[18] $ 10,103      
Investment cost [2],[8],[11],[18] 10,050      
Total investments at fair value [8],[11],[18] $ 10,167      
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.95% 3.95%    
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.95% 4.95%    
Consumer & Business Services | Thumbtack, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[18] $ 844      
Total investments at fair value [18] $ 280      
Acquisition Date [9] May 01, 2018 May 01, 2018    
Shares | shares [18] 267,225 267,225    
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-02 2025-02    
Investment Interest Rate Floor [7] 10.25% 10.25%    
Principal Amount [10],[13],[18],[19],[23],[24] $ 94,500      
Investment cost [2],[10],[13],[18],[19],[23],[24] 94,418      
Total investments at fair value [10],[13],[18],[19],[23],[24] $ 93,837      
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.00% 3.00%    
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 9.25% 9.25%    
Consumer & Business Services | Worldremit Group Limited | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [2] $ 155      
Total investments at fair value $ 194      
Shares | shares 79,083 79,083    
Consumer & Business Services | Worldremit Group Limited | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [2],[18],[19],[23],[24] $ 129      
Total investments at fair value [18],[19],[23],[24] $ 192      
Acquisition Date [9] Feb. 11, 2021 Feb. 11, 2021    
Shares | shares [18],[19],[23],[24] 77,215 77,215    
Consumer & Business Services | Worldremit Group Limited | Warrant Investment | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost [2],[19],[23],[24] $ 26      
Total investments at fair value [19],[23],[24] $ 2      
Acquisition Date [9] Aug. 27, 2021 Aug. 27, 2021    
Shares | shares [19],[23],[24] 1,868 1,868    
Consumer & Business Services | Udacity, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-09 2024-09    
Investment Interest Rate Floor [7] 7.75% 7.75%    
Investment Interest Rate Paid in Kind [7] 2.00% 2.00%    
Principal Amount [11],[18] $ 51,937      
Investment cost [2],[11],[18] 52,265      
Total investments at fair value [11],[18] $ 52,976      
Consumer & Business Services | Udacity, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.00% 3.00%    
Consumer & Business Services | Udacity, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.50% 4.50%    
Consumer & Business Services | Udacity, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[18] $ 218      
Total investments at fair value [18] $ 4      
Acquisition Date [9] Sep. 25, 2020 Sep. 25, 2020    
Shares | shares [18] 486,359 486,359    
Diversified Financial Services        
Investment Holdings [Line Items]        
Total investments at fair value $ 68,569   $ 65,073  
Diversified Financial Services | Debt Investments        
Investment Holdings [Line Items]        
Investment cost 36,567 [2]   33,738 [1]  
Total investments at fair value 33,700   32,465  
Diversified Financial Services | Equity        
Investment Holdings [Line Items]        
Investment cost 28,444 [2]   28,041 [1]  
Total investments at fair value $ 34,869   $ 32,608  
Diversified Financial Services | Gibraltar Business Capital, LLC | Unsecured        
Investment Holdings [Line Items]        
Maturity Date 2026-09 2026-09 2026-09 2026-09
Principal Amount $ 15,000 [27]   $ 15,000 [29]  
Investment Interest Rate Paid in Cash 14.50% [7] 14.50% [7] 14.50% [12] 14.50% [12]
Investment cost $ 14,715 [2],[27]   $ 14,662 [1],[29]  
Total investments at fair value 12,802 [27]   13,818 [29]  
Diversified Financial Services | Gibraltar Business Capital, LLC | Debt Investments        
Investment Holdings [Line Items]        
Principal Amount 25,000   25,000  
Investment cost 24,567 [2]   24,485 [1]  
Total investments at fair value 21,700   23,212  
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity        
Investment Holdings [Line Items]        
Investment cost 28,006 [2]   28,006 [1]  
Total investments at fair value $ 15,244   $ 20,618  
Shares | shares 11,432,752 11,432,752 11,432,752 11,432,752
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [2],[27] $ 26,122      
Total investments at fair value [27] $ 14,137      
Acquisition Date [9] Mar. 01, 2018 Mar. 01, 2018    
Shares | shares [27] 10,602,752 10,602,752    
Diversified Financial Services | Gibraltar Business Capital, LLC | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,884 [2],[27]   $ 1,884 [1],[29]  
Total investments at fair value $ 1,107 [27]   $ 1,225 [29]  
Acquisition Date Mar. 01, 2018 [9] Mar. 01, 2018 [9] Mar. 01, 2018 [6] Mar. 01, 2018 [6]
Shares | shares 830,000 [27] 830,000 [27] 830,000 [29] 830,000 [29]
Diversified Financial Services | Gibraltar Business Capital L L C One | Unsecured        
Investment Holdings [Line Items]        
Maturity Date 2026-09 2026-09 2026-09 2026-09
Principal Amount $ 10,000 [27]   $ 10,000 [29]  
Investment Interest Rate Paid in Cash 11.50% [7] 11.50% [7] 11.50% [12] 11.50% [12]
Investment cost $ 9,852 [2],[27]   $ 9,823 [1],[29]  
Total investments at fair value $ 8,898 [27]   9,394 [29]  
Diversified Financial Services | Gibraltar Business Capital L L C One | Equity | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [1],[29]     26,122  
Total investments at fair value [29]     $ 19,393  
Acquisition Date [6]     Mar. 01, 2018 Mar. 01, 2018
Shares | shares [29]     10,602,752 10,602,752
Diversified Financial Services | Hercules Adviser LLC | Unsecured        
Investment Holdings [Line Items]        
Maturity Date 2025-06 2025-06 2023-05 2023-05
Principal Amount $ 12,000 [27]   $ 8,850 [29]  
Investment Interest Rate Paid in Cash 5.00% [7] 5.00% [7] 5.00% [12] 5.00% [12]
Investment cost $ 12,000 [2],[27]   $ 8,850 [1],[29]  
Total investments at fair value 12,000 [27]   8,850 [29]  
Diversified Financial Services | Hercules Adviser LLC | Equity | Member Units        
Investment Holdings [Line Items]        
Investment cost 35 [2],[27]   35 [1],[29]  
Total investments at fair value $ 19,153 [27]   $ 11,990 [29]  
Acquisition Date Mar. 26, 2021 [9] Mar. 26, 2021 [9] Mar. 26, 2021 [6] Mar. 26, 2021 [6]
Shares | shares 1 [27] 1 [27] 1 [29] 1 [29]
Diversified Financial Services | Newfront Insurance Holdings, Inc. | Convertible Debt        
Investment Holdings [Line Items]        
Maturity Date     2022-08 2022-08
Investment Interest Rate Floor [12]     0.19% 0.19%
Investment Interest Rate Paid in Kind [12]     0.19% 0.19%
Principal Amount [30]     $ 403  
Investment cost [1],[30]     403  
Total investments at fair value [30]     403  
Diversified Financial Services | Newfront Insurance Holdings, Inc. | Equity | Preferred Series D-2        
Investment Holdings [Line Items]        
Investment cost [2] $ 403      
Total investments at fair value $ 472      
Acquisition Date [9] Sep. 30, 2021 Sep. 30, 2021    
Shares | shares 210,282 210,282    
Drug Delivery        
Investment Holdings [Line Items]        
Total investments at fair value $ 90   368  
Drug Delivery | Equity        
Investment Holdings [Line Items]        
Investment cost 3,638 [2]   3,638 [1]  
Total investments at fair value 89   305  
Drug Delivery | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 465 [2]   465 [1]  
Total investments at fair value 1   63  
Drug Delivery | PDS Biotechnology Corporation | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] 390      
Total investments at fair value [9] $ 1      
Acquisition Date [9] Aug. 28, 2014 Aug. 28, 2014    
Shares | shares [9] 3,929 3,929    
Drug Delivery | Aerami Therapeutics Holdings, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 74 [2]   74 [1]  
Total investments at fair value   $ 0  
Acquisition Date Sep. 30, 2015 [9] Sep. 30, 2015 [9] Sep. 30, 2015 [6] Sep. 30, 2015 [6]
Shares | shares 110,882 110,882 110,882 110,882
Drug Delivery | PDS Biotechnology Corporation (p.k.a. Edge Therapeutics, Inc.) | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 309 [2],[9]   $ 309 [1],[6]  
Total investments at fair value $ 33 [9]   $ 20 [6]  
Acquisition Date Apr. 06, 2015 [9] Apr. 06, 2015 [9] Apr. 06, 2015 [6] Apr. 06, 2015 [6]
Shares | shares 2,498 [9] 2,498 [9] 2,498 [6] 2,498 [6]
Drug Delivery | PDS Biotechnology Corporation (p.k.a. Edge Therapeutics, Inc.) | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 390  
Total investments at fair value [6]     $ 1  
Acquisition Date [6]     Aug. 28, 2014 Aug. 28, 2014
Shares | shares [6]     3,929 3,929
Drug Delivery | BioQ Pharma Incorporated | Equity | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost $ 500 [2]   $ 500 [1]  
Total investments at fair value $ 33   $ 168  
Acquisition Date Dec. 08, 2015 [9] Dec. 08, 2015 [9] Dec. 08, 2015 [6] Dec. 08, 2015 [6]
Shares | shares 165,000 165,000 165,000 165,000
Drug Delivery | BioQ Pharma Incorporated | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1 [2]   $ 1 [1]  
Total investments at fair value   $ 62  
Acquisition Date Oct. 27, 2014 [9] Oct. 27, 2014 [9] Oct. 27, 2014 [6] Oct. 27, 2014 [6]
Shares | shares 459,183 459,183 459,183 459,183
Drug Delivery | Aytu BioScience, Inc. (p.k.a. Neos Therapeutics, Inc.) | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,500 [2],[9]   $ 1,500 [1],[6]  
Total investments at fair value $ 3 [9]   $ 18 [6]  
Acquisition Date Mar. 28, 2014 [9] Mar. 28, 2014 [9] Mar. 28, 2014 [6] Mar. 28, 2014 [6]
Shares | shares 13,600 [9] 13,600 [9] 13,600 [6] 13,600 [6]
Drug Delivery | AcelRx Pharmaceuticals, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,329 [2],[9]   $ 1,329 [1],[6]  
Total investments at fair value $ 20 [9]   $ 99 [6]  
Acquisition Date Dec. 10, 2018 [9] Dec. 10, 2018 [9] Dec. 10, 2018 [6] Dec. 10, 2018 [6]
Shares | shares 8,836 [9] 8,836 [9] 176,730 [6] 176,730 [6]
Drug Discovery & Development        
Investment Holdings [Line Items]        
Total investments at fair value $ 1,150,707   $ 967,383  
Drug Discovery & Development | Investment Funds & Vehicles [Member]        
Investment Holdings [Line Items]        
Investment cost [2] 3,118      
Total investments at fair value 3,518      
Drug Discovery & Development | Debt Investments        
Investment Holdings [Line Items]        
Investment cost 1,107,352 [2]   936,457 [1]  
Total investments at fair value 1,101,430   935,964  
Drug Discovery & Development | Equity        
Investment Holdings [Line Items]        
Investment cost 43,971 [2]   33,401 [1]  
Total investments at fair value 37,315   24,860  
Drug Discovery & Development | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 7,466 [2]   7,393 [1]  
Total investments at fair value 8,444   4,745  
Drug Discovery & Development | Forbion Growth Opportunities Fund I I C V | Investment Funds & Vehicles [Member]        
Investment Holdings [Line Items]        
Investment cost [2],[8],[23],[24] 419      
Total investments at fair value [8],[23],[24] $ 438      
Acquisition Date [9] Jun. 23, 2022 Jun. 23, 2022    
Drug Discovery & Development | Kineta, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 110      
Total investments at fair value [9] $ 0      
Acquisition Date [9] Dec. 20, 2019 Dec. 20, 2019    
Shares | shares [9] 2,202 2,202    
Drug Discovery & Development | Akero Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-01 2027-01    
Investment Interest Rate Floor [7] 7.65% 7.65%    
Principal Amount [8],[17],[23] $ 5,000      
Investment cost [2],[8],[17],[23] 4,986      
Total investments at fair value [8],[17],[23] $ 5,039      
Drug Discovery & Development | Akero Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 5.85% 5.85%    
Drug Discovery & Development | Akero Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.65% 3.65%    
Drug Discovery & Development | Akero Therapeutics, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9],[23] $ 1,000      
Total investments at fair value [9],[23] $ 2,108      
Acquisition Date [9] Sep. 19, 2022 Sep. 19, 2022    
Shares | shares [9],[23] 38,461 38,461    
Drug Discovery & Development | Akero Therapeutics, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9],[23] $ 56      
Total investments at fair value [9],[23] $ 674      
Acquisition Date [9] Jun. 15, 2022 Jun. 15, 2022    
Shares | shares [9],[23] 18,360 18,360    
Drug Discovery & Development | Alladapt Immunotherapeutics Inc | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-09 2026-09    
Investment Interest Rate Floor [7] 8.40% 8.40%    
Principal Amount [8],[17] $ 15,000      
Investment cost [2],[8],[17] 14,920      
Total investments at fair value [8],[17] $ 14,920      
Drug Discovery & Development | Alladapt Immunotherapeutics Inc | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 10.60% 10.60%    
Drug Discovery & Development | Alladapt Immunotherapeutics Inc | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 10.90% 10.90%    
Drug Discovery & Development | Alladapt Immunotherapeutics Inc | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.65% 3.65%    
Drug Discovery & Development | ATAI Life Sciences N.V. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-08 2026-08    
Investment Interest Rate Floor [7] 8.55% 8.55%    
Principal Amount [23],[24] $ 10,500      
Investment cost [2],[23],[24] 10,513      
Total investments at fair value [23],[24] $ 10,513      
Drug Discovery & Development | ATAI Life Sciences N.V. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 6.95% 6.95%    
Drug Discovery & Development | ATAI Life Sciences N.V. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.55% 4.55%    
Drug Discovery & Development | Provention Bio, Inc. [Member] | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-09 2027-09    
Investment Interest Rate Floor [7] 8.20% 8.20%    
Principal Amount [8] $ 25,000      
Investment cost [2],[8] 24,670      
Total investments at fair value [8] $ 24,670      
Drug Discovery & Development | Provention Bio, Inc. [Member] | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 6.60% 6.60%    
Drug Discovery & Development | Provention Bio, Inc. [Member] | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 2.70% 2.70%    
Drug Discovery & Development | Provention Bio, Inc. [Member] | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 281      
Total investments at fair value [9] $ 677      
Acquisition Date [9] Sep. 15, 2022 Sep. 15, 2022    
Shares | shares [9] 111,934 111,934    
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-01 2026-01    
Investment Interest Rate Floor [7] 7.50% 7.50%    
Principal Amount [25] $ 5,000      
Investment cost [2],[25] 4,957      
Total investments at fair value [25] $ 4,946      
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.80% 3.80%    
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.25% 4.25%    
Drug Discovery & Development | Redshift Bioanalytics, Inc. | Warrant Investment | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost [2],[25] $ 20      
Total investments at fair value [25] $ 21      
Acquisition Date [9] Mar. 23, 2022 Mar. 23, 2022    
Shares | shares [25] 475,510 475,510    
Drug Discovery & Development | Replimune Group, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-10 2027-10    
Investment Interest Rate Floor [7] 7.25% 7.25%    
Investment Interest Rate Paid in Kind [7] 1.50% 1.50%    
Principal Amount [8],[11],[23] $ 20,754      
Investment cost [2],[8],[11],[23] 20,656      
Total investments at fair value [8],[11],[23] $ 20,656      
Drug Discovery & Development | Replimune Group, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.95% 4.95%    
Drug Discovery & Development | Replimune Group, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 9.00% 9.00%    
Drug Discovery & Development | Replimune Group, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 1.75% 1.75%    
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-02 2027-02    
Investment Interest Rate Floor [7] 8.45% 8.45%    
Principal Amount [8],[17],[23] $ 8,250      
Investment cost [2],[8],[17],[23] 8,274      
Total investments at fair value [8],[17],[23] $ 8,423      
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.75% 4.75%    
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.20% 5.20%    
Drug Discovery & Development | Tarsus Pharmaceuticals, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9],[23] $ 2,100      
Total investments at fair value [9],[23] $ 2,280      
Acquisition Date [9] May 05, 2022 May 05, 2022    
Shares | shares [9],[23] 155,555 155,555    
Drug Discovery & Development | Iveric Bio, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-08 2027-08    
Investment Interest Rate Floor [7] 8.75% 8.75%    
Principal Amount [18],[23] $ 49,500      
Investment cost [2],[18],[23] 49,090      
Total investments at fair value [18],[23] $ 49,090      
Drug Discovery & Development | Iveric Bio, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.25% 4.25%    
Drug Discovery & Development | Iveric Bio, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 10.25% 10.25%    
Drug Discovery & Development | Iveric Bio, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.00% 4.00%    
Drug Discovery & Development | AmplifyBio, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-01 2027-01    
Investment Interest Rate Floor [7] 9.50% 9.50%    
Principal Amount [25] $ 24,000      
Investment cost [2],[25] 23,663      
Total investments at fair value [25] $ 23,663      
Drug Discovery & Development | AmplifyBio, LLC | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 5.85% 5.85%    
Drug Discovery & Development | AmplifyBio, LLC | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 10.75% 10.75%    
Drug Discovery & Development | AmplifyBio, LLC | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 2.50% 2.50%    
Drug Discovery & Development | AmplifyBio, LLC | Warrant Investment | Class A Units        
Investment Holdings [Line Items]        
Investment cost [2],[25] $ 238      
Total investments at fair value [25] $ 256      
Acquisition Date [9] Dec. 27, 2022 Dec. 27, 2022    
Shares | shares [25] 69,239 69,239    
Drug Discovery & Development | HilleVax, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-05 2027-05    
Investment Interest Rate Floor [7] 4.55% 4.55%    
Investment Interest Rate Paid in Kind [7] 2.85% 2.85%    
Principal Amount [8],[11],[25] $ 12,072      
Investment cost [2],[8],[11],[25] 12,043      
Total investments at fair value [8],[11],[25] $ 11,333      
Drug Discovery & Development | HilleVax, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 7.15% 7.15%    
Drug Discovery & Development | HilleVax, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 6.05% 6.05%    
Drug Discovery & Development | HilleVax, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 1.05% 1.05%    
Drug Discovery & Development | HilleVax, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 4,000      
Total investments at fair value [9] $ 3,937      
Acquisition Date [9] May 03, 2022 May 03, 2022    
Shares | shares [9] 235,295 235,295    
Drug Discovery & Development | Kura Oncology, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-11 2027-11    
Investment Interest Rate Floor [7] 8.65% 8.65%    
Principal Amount [8],[23],[25] $ 5,500      
Investment cost [2],[8],[23],[25] 5,448      
Total investments at fair value [8],[23],[25] $ 5,448      
Drug Discovery & Development | Kura Oncology, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 15.13% 15.13%    
Drug Discovery & Development | Kura Oncology, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 2.40% 2.40%    
Drug Discovery & Development | Kura Oncology, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9],[23],[25] $ 88      
Total investments at fair value [9],[23],[25] $ 59      
Acquisition Date [9] Nov. 02, 2022 Nov. 02, 2022    
Shares | shares [9],[23],[25] 14,342 14,342    
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-05 2026-05    
Investment Interest Rate Floor [7] 7.45% 7.45%    
Principal Amount [8],[23] $ 34,000      
Investment cost [2],[8],[23] 33,945      
Total investments at fair value [8],[23] $ 33,987      
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 5.35% 5.35%    
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.95% 3.95%    
Drug Discovery & Development | Madrigal Pharmaceutical, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9],[23] $ 177      
Total investments at fair value [9],[23] $ 1,977      
Acquisition Date [9] May 09, 2022 May 09, 2022    
Shares | shares [9],[23] 10,131 10,131    
Drug Discovery & Development | Forbion Growth Opportunities Fund I C V | Investment Funds & Vehicles [Member]        
Investment Holdings [Line Items]        
Investment cost [2],[8],[23],[24] $ 2,699      
Total investments at fair value [8],[23],[24] $ 3,080      
Acquisition Date [9] Nov. 16, 2020 Nov. 16, 2020    
Drug Discovery & Development | Dynavax Technologies | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 550 [2],[9],[23]   550 [1],[4],[6]  
Total investments at fair value $ 213 [9],[23]   $ 281 [4],[6]  
Acquisition Date Jul. 22, 2015 [9] Jul. 22, 2015 [9] Jul. 22, 2015 [6] Jul. 22, 2015 [6]
Shares | shares 20,000 [9],[23] 20,000 [9],[23] 20,000 [4],[6] 20,000 [4],[6]
Drug Discovery & Development | Genocea Biosciences Inc | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 2,000  
Total investments at fair value [6]     $ 32  
Acquisition Date [6]     Nov. 20, 2014 Nov. 20, 2014
Shares | shares [6]     27,933 27,933
Drug Discovery & Development | Genocea Biosciences Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 165  
Total investments at fair value [6]     $ 1  
Acquisition Date [6]     Apr. 24, 2018 Apr. 24, 2018
Shares | shares [6]     41,176 41,176
Drug Discovery & Development | NorthSea Therapeutics | Equity | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost $ 2,000 [2],[23],[24]   $ 2,000 [1],[4],[5]  
Total investments at fair value $ 1,476 [23],[24]   $ 2,000 [4],[5]  
Acquisition Date Dec. 15, 2021 [9] Dec. 15, 2021 [9] Dec. 15, 2021 [6] Dec. 15, 2021 [6]
Shares | shares 983 [23],[24] 983 [23],[24] 983 [4],[5] 983 [4],[5]
Drug Discovery & Development | Sio Gene Therapies, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,269 [2],[9]   $ 1,269 [1],[4],[6]  
Total investments at fair value $ 7 [9]   $ 21 [4],[6]  
Acquisition Date Feb. 02, 2017 [9] Feb. 02, 2017 [9] Feb. 02, 2017 [6] Feb. 02, 2017 [6]
Shares | shares 16,228 [9] 16,228 [9] 16,228 [4],[6] 16,228 [4],[6]
Drug Discovery & Development | Valo Health L L C | Equity        
Investment Holdings [Line Items]        
Investment cost [2] $ 4,000      
Total investments at fair value $ 3,075      
Shares | shares 680,410 680,410    
Drug Discovery & Development | Valo Health L L C | Equity | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost $ 3,000 [2]   $ 3,000 [1]  
Total investments at fair value $ 2,063   $ 4,650  
Acquisition Date Dec. 11, 2020 [9] Dec. 11, 2020 [9] Dec. 11, 2020 [6] Dec. 11, 2020 [6]
Shares | shares 510,308 510,308 510,308 510,308
Drug Discovery & Development | Valo Health L L C | Equity | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost [2] $ 1,000      
Total investments at fair value $ 1,012      
Acquisition Date [9] Oct. 31, 2022 Oct. 31, 2022    
Shares | shares 170,102 170,102    
Drug Discovery & Development | Paratek Pharmaceuticals, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 2,744 [2],[9]   $ 2,744 [1],[6]  
Total investments at fair value $ 143 [9]   $ 343 [6]  
Acquisition Date Feb. 26, 2007 [9] Feb. 26, 2007 [9] Feb. 26, 2007 [6] Feb. 26, 2007 [6]
Shares | shares 76,362 [9] 76,362 [9] 76,362 [6] 76,362 [6]
Drug Discovery & Development | Paratek Pharmaceuticals, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 520 [2],[9]   $ 546 [1],[6]  
Total investments at fair value $ 34 [9]   $ 427 [6]  
Acquisition Date Aug. 01, 2018 [9] Aug. 01, 2018 [9] Jun. 27, 2017 [6] Jun. 27, 2017 [6]
Shares | shares 426,866 [9] 426,866 [9] 432,240 [6] 432,240 [6]
Drug Discovery & Development | Rocket Pharmaceuticals, Ltd. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,500 [2],[9]   $ 1,500 [1],[6]  
Total investments at fair value $ 18 [9]   $ 21 [6]  
Acquisition Date Aug. 22, 2007 [9] Aug. 22, 2007 [9] Aug. 22, 2007 [6] Aug. 22, 2007 [6]
Shares | shares 944 [9] 944 [9] 944 [6] 944 [6]
Drug Discovery & Development | Savara, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 203 [2],[9]   $ 202 [1],[6]  
Total investments at fair value $ 17 [9]   $ 14 [6]  
Acquisition Date Aug. 11, 2015 [9] Aug. 11, 2015 [9] Aug. 11, 2015 [6] Aug. 11, 2015 [6]
Shares | shares 11,119 [9] 11,119 [9] 11,119 [6] 11,119 [6]
Drug Discovery & Development | Tricida, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 863 [2],[9]   $ 863 [1],[6]  
Total investments at fair value $ 11 [9]   $ 658 [6]  
Acquisition Date Feb. 28, 2018 [9] Feb. 28, 2018 [9] Feb. 28, 2018 [6] Feb. 28, 2018 [6]
Shares | shares 68,816 [9] 68,816 [9] 68,816 [6] 68,816 [6]
Drug Discovery & Development | Tricida, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 280 [2],[9]   $ 280 [1],[6]  
Total investments at fair value $ 1 [9]   $ 20 [6]  
Acquisition Date Mar. 27, 2019 [9] Mar. 27, 2019 [9] Mar. 27, 2019 [6] Mar. 27, 2019 [6]
Shares | shares 31,352 [9] 31,352 [9] 31,352 [6] 31,352 [6]
Drug Discovery & Development | Concert Pharmaceuticals, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,367 [2],[9],[23]   $ 1,367 [1],[4],[6]  
Total investments at fair value $ 413 [9],[23]   $ 223 [4],[6]  
Acquisition Date Feb. 13, 2019 [9] Feb. 13, 2019 [9] Feb. 13, 2019 [6] Feb. 13, 2019 [6]
Shares | shares 70,796 [9],[23] 70,796 [9],[23] 70,796 [4],[6] 70,796 [4],[6]
Drug Discovery & Development | Concert Pharmaceuticals, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[4],[6]     $ 178  
Total investments at fair value [4],[6]     $ 3  
Acquisition Date [6]     Jun. 08, 2017 Jun. 08, 2017
Shares | shares [4],[6]     61,273 61,273
Drug Discovery & Development | Gritstone Bio, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-07 2027-07    
Investment Interest Rate Floor [7] 7.15% 7.15%    
Investment Interest Rate Paid in Kind [7] 2.00% 2.00%    
Principal Amount [8],[11] $ 15,113      
Investment cost [2],[8],[11] 15,109      
Total investments at fair value [8],[11] $ 15,109      
Drug Discovery & Development | Gritstone Bio, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 5.75% 5.75%    
Drug Discovery & Development | Gritstone Bio, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 8.65% 8.65%    
Drug Discovery & Development | Gritstone Bio, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.15% 3.15%    
Drug Discovery & Development | Gritstone Bio, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 1,000      
Total investments at fair value [9] $ 1,527      
Acquisition Date [9] Oct. 26, 2022 Oct. 26, 2022    
Shares | shares [9] 442,477 442,477    
Drug Discovery & Development | Dare Biosciences, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,000 [2],[9]   $ 1,000 [1],[6]  
Total investments at fair value $ 11 [9]   $ 27 [6]  
Acquisition Date Jan. 08, 2015 [9] Jan. 08, 2015 [9] Jan. 08, 2015 [6] Jan. 08, 2015 [6]
Shares | shares 13,550 [9] 13,550 [9] 13,550 [6] 13,550 [6]
Drug Discovery & Development | Applied Molecular Transport | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 42 [2],[9],[23]   $ 42 [1],[4],[6]  
Total investments at fair value $ 0 [9],[23]   $ 14 [4],[6]  
Acquisition Date Apr. 06, 2021 [9] Apr. 06, 2021 [9] Apr. 06, 2021 [6] Apr. 06, 2021 [6]
Shares | shares 1,000 [9],[23] 1,000 [9],[23] 1,000 [4],[6] 1,000 [4],[6]
Drug Discovery & Development | Avalo Therapeutics Inc P K Cerecor Inc | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,000 [2],[9]   $ 1,000 [1],[6]  
Total investments at fair value $ 50 [9]   $ 202 [6]  
Acquisition Date Aug. 19, 2014 [9] Aug. 19, 2014 [9] Aug. 19, 2014 [6] Aug. 19, 2014 [6]
Shares | shares 9,924 [9] 9,924 [9] 119,087 [6] 119,087 [6]
Drug Discovery & Development | Albireo Pharma, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-07 2024-07
Investment Interest Rate Floor [12]     9.15% 9.15%
Principal Amount [4],[15]     $ 10,000  
Investment cost [1],[4],[15]     10,229  
Total investments at fair value [4],[15]     $ 10,268  
Drug Discovery & Development | Albireo Pharma, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     6.95% 6.95%
Drug Discovery & Development | Albireo Pharma, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.90% 5.90%
Drug Discovery & Development | Albireo Pharma, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,000 [2],[9],[23]   $ 1,000 [1],[4],[6]  
Total investments at fair value $ 540 [9],[23]   $ 582 [4],[6]  
Acquisition Date Sep. 14, 2020 [9] Sep. 14, 2020 [9] Sep. 14, 2020 [6] Sep. 14, 2020 [6]
Shares | shares 25,000 [9],[23] 25,000 [9],[23] 25,000 [4],[6] 25,000 [4],[6]
Drug Discovery & Development | Albireo Pharma, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 61 [2],[9],[23]   $ 61 [1],[4],[6]  
Total investments at fair value $ 31 [9],[23]   $ 42 [4],[6]  
Acquisition Date Jun. 08, 2020 [9] Jun. 08, 2020 [9] Jun. 08, 2020 [6] Jun. 08, 2020 [6]
Shares | shares 5,311 [9],[23] 5,311 [9],[23] 5,311 [4],[6] 5,311 [4],[6]
Drug Discovery & Development | Aldeyra Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-10 2024-10 2023-10 2023-10
Investment Interest Rate Floor 8.60% [7] 8.60% [7] 8.60% [12] 8.60% [12]
Principal Amount $ 15,000 [13]   $ 15,000  
Investment cost 15,879 [2],[13]   15,639 [1]  
Total investments at fair value $ 15,974 [13]   $ 15,653  
Drug Discovery & Development | Aldeyra Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 8.90% [7] 8.90% [7] 6.95% [12] 6.95% [12]
Drug Discovery & Development | Aldeyra Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 3.10% [7] 3.10% [7] 3.10% [12] 3.10% [12]
Drug Discovery & Development | Applied Genetic Technologies Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-04 2024-04
Investment Interest Rate Floor [12]     9.75% 9.75%
Principal Amount     $ 20,000  
Investment cost [1]     20,416  
Total investments at fair value     $ 20,339  
Drug Discovery & Development | Applied Genetic Technologies Corporation | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     6.95% 6.95%
Drug Discovery & Development | Applied Genetic Technologies Corporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     6.50% 6.50%
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-09 2024-09 2024-09 2024-09
Investment Interest Rate Floor 9.65% [7] 9.65% [7] 9.65% [12] 9.65% [12]
Principal Amount $ 40,000 [13],[25]   $ 40,000 [15],[31]  
Investment cost 41,644 [2],[13],[25]   40,842 [1],[15],[31]  
Total investments at fair value $ 43,183 [13],[25]   $ 40,776 [15],[31]  
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 6.95% [7] 6.95% [7] 6.95% [12] 6.95% [12]
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 15.00% 15.00%    
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.40% [7] 6.40% [7] 6.40% [12] 6.40% [12]
Drug Discovery & Development | Aveo Pharmaceuticals, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,715 [2],[9]   $ 1,715 [1],[6]  
Total investments at fair value $ 2,843 [9]   $ 892 [6]  
Acquisition Date Jul. 31, 2011 [9] Jul. 31, 2011 [9] Jul. 31, 2011 [6] Jul. 31, 2011 [6]
Shares | shares 190,179 [9] 190,179 [9] 190,179 [6] 190,179 [6]
Drug Discovery & Development | Acacia Pharma Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 304 [2],[23],[24]   $ 305 [1],[4],[5],[6]  
Total investments at fair value $ 0 [23],[24]   $ 6 [4],[5],[6]  
Acquisition Date Jun. 29, 2018 [9] Jun. 29, 2018 [9] Jun. 29, 2018 [6] Jun. 29, 2018 [6]
Shares | shares 201,330 [23],[24] 201,330 [23],[24] 201,330 [4],[5],[6] 201,330 [4],[5],[6]
Drug Discovery & Development | ADMA Biologics, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 166 [2],[9]   $ 295 [1],[6]  
Total investments at fair value $ 10 [9]   $ 1 [6]  
Acquisition Date Feb. 24, 2014 [9] Feb. 24, 2014 [9] Dec. 21, 2012 [6] Dec. 21, 2012 [6]
Shares | shares 58,000 [9] 58,000 [9] 89,750 [6] 89,750 [6]
Drug Discovery & Development | Axsome Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-10 2026-10 2026-10 2026-10
Investment Interest Rate Floor 8.95% [7] 8.95% [7] 8.95% [12] 8.95% [12]
Principal Amount $ 81,725 [8],[13],[18],[19],[23]   $ 50,000 [4],[32]  
Investment cost 81,631 [2],[8],[13],[18],[19],[23]   49,542 [1],[4],[32]  
Total investments at fair value $ 78,074 [8],[13],[18],[19],[23]   $ 48,859 [4],[32]  
Drug Discovery & Development | Axsome Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 5.31% [7] 5.31% [7] 5.82% [12] 5.82% [12]
Drug Discovery & Development | Axsome Therapeutics, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 10.70% 10.70%    
Drug Discovery & Development | Axsome Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.70% [7] 5.70% [7] 5.70% [12] 5.70% [12]
Drug Discovery & Development | Axsome Therapeutics, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9],[19],[23] $ 4,165      
Total investments at fair value [9],[19],[23] $ 9,797      
Acquisition Date [9] May 09, 2022 May 09, 2022    
Shares | shares [9],[19],[23] 127,021 127,021    
Drug Discovery & Development | Axsome Therapeutics, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 880 [2],[9],[18],[19],[23]   $ 681 [1],[4],[6]  
Total investments at fair value $ 1,590 [9],[18],[19],[23]   $ 142 [4],[6]  
Acquisition Date Sep. 25, 2020 [9] Sep. 25, 2020 [9] Sep. 25, 2020 [6] Sep. 25, 2020 [6]
Shares | shares 40,396 [9],[18],[19],[23] 40,396 [9],[18],[19],[23] 15,541 [4],[6] 15,541 [4],[6]
Drug Discovery & Development | Brickell Biotech, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 119 [2],[9]   $ 119 [1],[6]  
Total investments at fair value $ 0 [9]   $ 0 [6]  
Acquisition Date Feb. 18, 2016 [9] Feb. 18, 2016 [9] Feb. 18, 2016 [6] Feb. 18, 2016 [6]
Shares | shares 200 [9] 200 [9] 9,005 [6] 9,005 [6]
Drug Discovery & Development | Bicycle Therapeutics PLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-07 2025-07 2024-10 2024-10
Investment Interest Rate Floor 8.05% [7] 8.05% [7] 8.85% [12] 8.85% [12]
Principal Amount $ 11,500 [13],[18],[23],[24]   $ 24,000 [3],[4],[5],[15],[32]  
Investment cost 11,757 [2],[13],[18],[23],[24]   24,271 [1],[3],[4],[5],[15],[32]  
Total investments at fair value $ 11,435 [13],[18],[23],[24]   $ 24,454 [3],[4],[5],[15],[32]  
Drug Discovery & Development | Bicycle Therapeutics PLC | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 5.00% [7] 5.00% [7] 5.00% [12] 5.00% [12]
Drug Discovery & Development | Bicycle Therapeutics PLC | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 9.05% 9.05%    
Drug Discovery & Development | Bicycle Therapeutics PLC | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 4.55% [7] 4.55% [7] 5.60% [12] 5.60% [12]
Drug Discovery & Development | Bicycle Therapeutics PLC | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,871 [2],[9],[23],[24]   $ 1,871 [1],[4],[5],[6]  
Total investments at fair value $ 2,904 [9],[23],[24]   $ 5,971 [4],[5],[6]  
Acquisition Date Oct. 05, 2020 [9] Oct. 05, 2020 [9] Oct. 05, 2020 [6] Oct. 05, 2020 [6]
Shares | shares 98,100 [9],[23],[24] 98,100 [9],[23],[24] 98,100 [4],[5],[6] 98,100 [4],[5],[6]
Drug Discovery & Development | BiomX, INC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-09 2025-09 2025-09 2025-09
Investment Interest Rate Floor 8.95% [7] 8.95% [7] 8.95% [12] 8.95% [12]
Principal Amount $ 9,000 [13],[23],[24]   $ 9,000 [4],[5],[15]  
Investment cost 9,174 [2],[13],[23],[24]   8,980 [1],[4],[5],[15]  
Total investments at fair value $ 9,052 [13],[23],[24]   $ 8,980 [4],[5],[15]  
Drug Discovery & Development | BiomX, INC | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 6.55% [7] 6.55% [7] 6.55% [12] 6.55% [12]
Drug Discovery & Development | BiomX, INC | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.70% [7] 5.70% [7] 5.70% [12] 5.70% [12]
Drug Discovery & Development | BridgeBio Pharma, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-11 2026-11 2026-11 2026-11
Principal Amount $ 37,312 [11],[17],[18]   $ 38,000  
Investment Interest Rate Paid in Cash 9.00% [7] 9.00% [7] 9.00% [12] 9.00% [12]
Investment cost $ 37,039 [2],[11],[17],[18]   $ 37,462 [1]  
Total investments at fair value $ 33,344 [11],[17],[18]   $ 37,462  
Drug Discovery & Development | BridgeBio Pharma, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 2.00% [7] 2.00% [7] 2.00% [12] 2.00% [12]
Drug Discovery & Development | BridgeBio Pharma, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 2,255 [2],[9]   $ 2,255 [1],[6]  
Total investments at fair value $ 1,763 [9]   $ 3,859 [6]  
Acquisition Date Jun. 21, 2018 [9] Jun. 21, 2018 [9] Jun. 21, 2018 [6] Jun. 21, 2018 [6]
Shares | shares 231,329 [9] 231,329 [9] 231,329 [6] 231,329 [6]
Drug Discovery & Development | Cellarity, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-06 2026-06 2026-06 2026-06
Investment Interest Rate Floor 8.95% [7] 8.95% [7] 8.95% [12] 8.95% [12]
Principal Amount $ 30,000 [17],[25]   $ 30,000 [31]  
Investment cost 29,841 [2],[17],[25]   29,422 [1],[31]  
Total investments at fair value $ 30,097 [17],[25]   $ 29,422 [31]  
Drug Discovery & Development | Cellarity, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 3.75% [7] 3.75% [7] 3.75% [12] 3.75% [12]
Drug Discovery & Development | Cellarity, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.70% [7] 5.70% [7] 5.70% [12] 5.70% [12]
Drug Discovery & Development | Cellarity, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost $ 287 [2],[25]   $ 287 [1],[31]  
Total investments at fair value $ 318 [25]   $ 287 [31]  
Acquisition Date Dec. 08, 2021 [9] Dec. 08, 2021 [9] Dec. 08, 2021 [6] Dec. 08, 2021 [6]
Shares | shares 100,000 [25] 100,000 [25] 100,000 [31] 100,000 [31]
Drug Discovery & Development | Center for Breakthrough Medicines Holdings, LLC [Member] | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2023-05 2023-05
Investment Interest Rate Floor [12]     8.75% 8.75%
Principal Amount     $ 5,000  
Investment cost [1]     5,005  
Total investments at fair value     $ 5,005  
Drug Discovery & Development | Center for Breakthrough Medicines Holdings, LLC [Member] | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     7.50% 7.50%
Drug Discovery & Development | Center for Breakthrough Medicines Holdings, LLC [Member] | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.50% 5.50%
Drug Discovery & Development | Century Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-04 2024-04 2024-04 2024-04
Investment Interest Rate Floor 9.55% [7] 9.55% [7] 9.55% [12] 9.55% [12]
Principal Amount $ 10,000 [13]   $ 10,000 [15]  
Investment cost 10,235 [2],[13]   10,075 [1],[15]  
Total investments at fair value $ 10,292 [13]   $ 10,361 [15]  
Drug Discovery & Development | Century Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 3.95% [7] 3.95% [7] 3.95% [12] 3.95% [12]
Drug Discovery & Development | Century Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.30% [7] 6.30% [7] 6.30% [12] 6.30% [12]
Drug Discovery & Development | Century Therapeutics, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 37 [2],[9]   $ 37 [1],[6]  
Total investments at fair value $ 3 [9]   $ 64 [6]  
Acquisition Date Sep. 14, 2020 [9] Sep. 14, 2020 [9] Sep. 14, 2020 [6] Sep. 14, 2020 [6]
Shares | shares 16,112 [9] 16,112 [9] 16,112 [6] 16,112 [6]
Drug Discovery & Development | Chemocentryx Inc One | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2022-12 2022-12
Investment Interest Rate Floor [12]     8.05% 8.05%
Principal Amount [4]     $ 18,951  
Investment cost [1],[4]     20,036  
Total investments at fair value [4]     $ 20,036  
Drug Discovery & Development | Chemocentryx Inc One | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     6.25% 6.25%
Drug Discovery & Development | Chemocentryx Inc One | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     3.30% 3.30%
Drug Discovery & Development | Chemocentryx Inc Two | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2025-02 2025-02
Investment Interest Rate Floor [12]     8.50% 8.50%
Principal Amount [4]     $ 5,000  
Investment cost [1],[4]     5,161  
Total investments at fair value [4]     $ 5,070  
Drug Discovery & Development | Chemocentryx Inc Two | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     7.15% 7.15%
Drug Discovery & Development | Chemocentryx Inc Two | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     3.25% 3.25%
Drug Discovery & Development | Chemocentryx, Inc. | Debt Investments        
Investment Holdings [Line Items]        
Principal Amount     $ 23,951  
Investment cost [1]     25,197  
Total investments at fair value     25,106  
Drug Discovery & Development | Chemocentryx, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[4],[6]     1,000  
Total investments at fair value [4],[6]     $ 628  
Acquisition Date [6]     Jun. 15, 2020 Jun. 15, 2020
Shares | shares [4],[6]     17,241 17,241
Drug Discovery & Development | Codiak Biosciences, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-10 2025-10 2025-10 2025-10
Investment Interest Rate Floor 8.25% [7] 8.25% [7] 8.25% [12] 8.25% [12]
Principal Amount $ 25,000 [13]   $ 25,000 [15]  
Investment cost 25,759 [2],[13]   25,459 [1],[15]  
Total investments at fair value $ 25,177 [13]   $ 25,316 [15]  
Drug Discovery & Development | Codiak Biosciences, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 5.50% [7] 5.50% [7] 5.50% [12] 5.50% [12]
Drug Discovery & Development | Codiak Biosciences, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.00% [7] 5.00% [7] 5.00% [12] 5.00% [12]
Drug Discovery & Development | Corium, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-09 2026-09 2026-09 2026-09
Investment Interest Rate Floor 8.95% [7] 8.95% [7] 8.95% [12] 8.95% [12]
Principal Amount $ 132,675 [17],[19]   $ 91,500 [21]  
Investment cost 133,557 [2],[17],[19]   90,997 [1],[21]  
Total investments at fair value $ 135,619 [17],[19]   $ 90,997 [21]  
Drug Discovery & Development | Corium, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 7.75% [7] 7.75% [7] 7.75% [12] 7.75% [12]
Drug Discovery & Development | Corium, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.70% [7] 5.70% [7] 5.70% [12] 5.70% [12]
Drug Discovery & Development | Eloxx Pharmaceuticals, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-04 2025-04 2025-04 2025-04
Investment Interest Rate Floor 9.50% [7] 9.50% [7] 9.50% [12] 9.50% [12]
Principal Amount $ 12,500 [25]   $ 12,500 [31]  
Investment cost 12,753 [2],[25]   12,443 [1],[31]  
Total investments at fair value $ 12,535 [25]   $ 12,443 [31]  
Drug Discovery & Development | Eloxx Pharmaceuticals, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 6.55% [7] 6.55% [7] 6.55% [12] 6.55% [12]
Drug Discovery & Development | Eloxx Pharmaceuticals, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.25% [7] 6.25% [7] 6.25% [12] 6.25% [12]
Drug Discovery & Development | Dermavant Sciences Ltd. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 101 [2],[23],[24]   $ 101 [1],[4],[32]  
Total investments at fair value $ 199 [23],[24]   $ 354 [4],[32]  
Acquisition Date May 31, 2019 [9] May 31, 2019 [9] May 31, 2019 [6] May 31, 2019 [6]
Shares | shares 223,642 [23],[24] 223,642 [23],[24] 223,642 [4],[32] 223,642 [4],[32]
Drug Discovery & Development | enGene, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-07 2025-07 2025-07 2025-07
Investment Interest Rate Floor 8.25% [7] 8.25% [7] 8.25% [12] 8.25% [12]
Principal Amount $ 11,000 [17],[18],[23],[24]   $ 7,000 [4],[5]  
Investment cost 11,072 [2],[17],[18],[23],[24]   6,858 [1],[4],[5]  
Total investments at fair value $ 11,067 [17],[18],[23],[24]   $ 6,858 [4],[5]  
Drug Discovery & Development | enGene, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 6.35% [7] 6.35% [7] 6.35% [12] 6.35% [12]
Drug Discovery & Development | enGene, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.00% [7] 5.00% [7] 5.00% [12] 5.00% [12]
Drug Discovery & Development | enGene, Inc. | Warrant Investment | Preferred Series 3        
Investment Holdings [Line Items]        
Investment cost [2],[18],[23],[24] $ 72      
Total investments at fair value [18],[23],[24] $ 28      
Acquisition Date [9] Dec. 30, 2021 Dec. 30, 2021    
Shares | shares [18],[23],[24] 133,692 133,692    
Drug Discovery & Development | enGene, Inc. | Warrant Investment | Preferred Series 3 Class C        
Investment Holdings [Line Items]        
Investment cost [1],[4],[5]     $ 64  
Total investments at fair value [4],[5]     $ 64  
Acquisition Date [6]     Dec. 30, 2021 Dec. 30, 2021
Shares | shares [4],[5]     84,714 84,714
Drug Discovery & Development | G1 Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-11 2026-11 2026-11 2026-11
Investment Interest Rate Floor 9.15% [7] 9.15% [7] 9.15% [12] 9.15% [12]
Principal Amount $ 58,125 [8],[13],[18],[25]   $ 58,125 [3],[4],[15],[31],[32]  
Investment cost 58,674 [2],[8],[13],[18],[25]   57,873 [1],[3],[4],[15],[31],[32]  
Total investments at fair value $ 58,407 [8],[13],[18],[25]   $ 57,874 [3],[4],[15],[31],[32]  
Drug Discovery & Development | G1 Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 9.86% [7] 9.86% [7] 9.86% [12] 9.86% [12]
Drug Discovery & Development | G1 Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.90% [7] 5.90% [7] 5.90% [12] 5.90% [12]
Drug Discovery & Development | Geron Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-10 2024-10 2024-10 2024-10
Investment Interest Rate Floor 9.00% [7] 9.00% [7] 9.00% [12] 9.00% [12]
Principal Amount $ 18,500 [17],[18],[23]   $ 32,500 [4],[32]  
Investment cost 19,109 [2],[17],[18],[23]   32,704 [1],[4],[32]  
Total investments at fair value $ 19,174 [17],[18],[23]   $ 32,744 [4],[32]  
Drug Discovery & Development | Geron Corporation | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 6.55% [7] 6.55% [7] 6.55% [12] 6.55% [12]
Drug Discovery & Development | Geron Corporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.75% [7] 5.75% [7] 5.75% [12] 5.75% [12]
Drug Discovery & Development | Hibercell, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-05 2025-05 2025-05 2025-05
Investment Interest Rate Floor 8.65% [7] 8.65% [7] 8.65% [12] 8.65% [12]
Principal Amount $ 17,000 [17],[25]   $ 17,000 [31]  
Investment cost 17,313 [2],[17],[25]   17,041 [1],[31]  
Total investments at fair value $ 17,265 [17],[25]   $ 17,014 [31]  
Drug Discovery & Development | Hibercell, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 4.95% [7] 4.95% [7] 4.95% [12] 4.95% [12]
Drug Discovery & Development | Hibercell, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.40% [7] 5.40% [7] 5.40% [12] 5.40% [12]
Drug Discovery & Development | Hibercell, Inc. | Equity | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost $ 4,250 [2],[25]   $ 4,250 [1],[31]  
Total investments at fair value $ 2,233 [25]   $ 3,264 [31]  
Acquisition Date May 07, 2021 [9] May 07, 2021 [9] May 07, 2021 [6] May 07, 2021 [6]
Shares | shares 3,466,840 [25] 3,466,840 [25] 3,466,840 [31] 3,466,840 [31]
Drug Discovery & Development | Humanigen, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2025-03 2025-03
Investment Interest Rate Floor [12]     8.75% 8.75%
Principal Amount [4],[30]     $ 20,000  
Investment cost [1],[4],[30]     20,235  
Total investments at fair value [4],[30]     $ 19,985  
Drug Discovery & Development | Humanigen, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     6.75% 6.75%
Drug Discovery & Development | Humanigen, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.50% 5.50%
Drug Discovery & Development | Humanigen, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 800 [2],[9],[23]   $ 800 [1],[4],[6]  
Total investments at fair value $ 5 [9],[23]   $ 161 [4],[6]  
Acquisition Date Mar. 31, 2021 [9] Mar. 31, 2021 [9] Mar. 31, 2021 [6] Mar. 31, 2021 [6]
Shares | shares 43,243 [9],[23] 43,243 [9],[23] 43,243 [4],[6] 43,243 [4],[6]
Drug Discovery & Development | Kaleido Biosciences, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-01 2024-01
Investment Interest Rate Floor [12]     9.35% 9.35%
Principal Amount [32]     $ 22,500  
Investment cost [1],[32]     23,505  
Total investments at fair value [32]     $ 23,384  
Drug Discovery & Development | Kaleido Biosciences, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     7.55% 7.55%
Drug Discovery & Development | Kaleido Biosciences, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     6.10% 6.10%
Drug Discovery & Development | Kaleido Biosciences, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 1,000  
Total investments at fair value [6]     $ 207  
Acquisition Date [6]     Feb. 10, 2021 Feb. 10, 2021
Shares | shares [6]     86,585 86,585
Drug Discovery & Development | Locus Biosciences, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-07 2025-07 2025-07 2025-07
Investment Interest Rate Floor 9.35% [7] 9.35% [7] 9.35% [12] 9.35% [12]
Principal Amount $ 8,000 [25]   $ 8,000 [31]  
Investment cost 8,120 [2],[25]   7,977 [1],[31]  
Total investments at fair value $ 8,085 [25]   $ 7,900 [31]  
Drug Discovery & Development | Locus Biosciences, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 4.95% [7] 4.95% [7] 4.95% [12] 4.95% [12]
Drug Discovery & Development | Locus Biosciences, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.10% [7] 6.10% [7] 6.10% [12] 6.10% [12]
Drug Discovery & Development | Nabriva Therapeutics | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2023-06 2023-06 2023-06 2023-06
Investment Interest Rate Floor 9.80% [7] 9.80% [7] 9.80% [12] 9.80% [12]
Principal Amount $ 2,079 [17],[23],[24]   $ 5,000 [4],[5]  
Investment cost 2,734 [2],[17],[23],[24]   5,500 [1],[4],[5]  
Total investments at fair value $ 2,804 [17],[23],[24]   $ 5,459 [4],[5]  
Drug Discovery & Development | Nabriva Therapeutics | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 9.95% [7] 9.95% [7] 6.95% [12] 6.95% [12]
Drug Discovery & Development | Nabriva Therapeutics | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 4.30% [7] 4.30% [7] 4.30% [12] 4.30% [12]
Drug Discovery & Development | Evofem Biosciences, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 266 [2],[9]   $ 266 [1],[6]  
Total investments at fair value [9] $ 0      
Acquisition Date Jun. 11, 2014 [9] Jun. 11, 2014 [9] Jun. 11, 2014 [6] Jun. 11, 2014 [6]
Shares | shares 520 [9] 520 [9] 7,806 [6] 7,806 [6]
Drug Discovery & Development | Motif Bio P L C | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[4]     $ 282  
Total investments at fair value [4]     $ 0  
Acquisition Date [6]     Jan. 27, 2020 Jan. 27, 2020
Shares | shares [4]     121,337,041 121,337,041
Drug Discovery & Development | Myovant Sciences, Ltd. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 460 [2],[9],[23],[24]   $ 460 [1],[4],[6]  
Total investments at fair value $ 958 [9],[23],[24]   $ 267 [4],[6]  
Acquisition Date Oct. 16, 2017 [9] Oct. 16, 2017 [9] Oct. 16, 2017 [6] Oct. 16, 2017 [6]
Shares | shares 73,710 [9],[23],[24] 73,710 [9],[23],[24] 73,710 [4],[6] 73,710 [4],[6]
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-10 2026-10 2026-10 2026-10
Investment Interest Rate Floor 5.50% [7] 5.50% [7] 5.50% [12] 5.50% [12]
Investment Interest Rate Paid in Kind 3.35% [7] 3.35% [7] 3.35% [12] 3.35% [12]
Principal Amount $ 94,737 [8],[11],[18],[19],[23],[25],[33]   $ 87,116 [3],[4],[20],[21],[31],[32]  
Investment cost 95,032 [2],[8],[11],[18],[19],[23],[25],[33]   86,075 [1],[3],[4],[20],[21],[31],[32]  
Total investments at fair value $ 93,916 [8],[11],[18],[19],[23],[25],[33]   $ 86,075 [3],[4],[20],[21],[31],[32]  
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 7.50% [7] 7.50% [7] 7.50% [12] 7.50% [12]
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 2.25% [7] 2.25% [7] 2.25% [12] 2.25% [12]
Drug Discovery & Development | Phathom Pharmaceuticals, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 848 [2],[9],[18],[19],[23],[25]   $ 848 [1],[4],[6],[21],[31]  
Total investments at fair value $ 101 [9],[18],[19],[23],[25]   $ 307 [4],[6],[21],[31]  
Acquisition Date Sep. 17, 2021 [9] Sep. 17, 2021 [9] Sep. 17, 2021 [6] Sep. 17, 2021 [6]
Shares | shares 64,687 [9],[18],[19],[23],[25] 64,687 [9],[18],[19],[23],[25] 64,687 [4],[6],[21],[31] 64,687 [4],[6],[21],[31]
Drug Discovery & Development | Scynexis, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-03 2025-03 2025-03 2025-03
Investment Interest Rate Floor 9.05% [7] 9.05% [7] 9.05% [12] 9.05% [12]
Principal Amount $ 18,667 [17],[18]   $ 16,000  
Investment cost 18,675 [2],[17],[18]   15,826 [1]  
Total investments at fair value $ 18,698 [17],[18]   $ 15,778  
Drug Discovery & Development | Scynexis, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 3.95% [7] 3.95% [7] 3.95% [12] 3.95% [12]
Drug Discovery & Development | Scynexis, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.80% [7] 5.80% [7] 5.80% [12] 5.80% [12]
Drug Discovery & Development | Scynexis, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 296 [2],[9],[18]   $ 188 [1],[6]  
Total investments at fair value $ 15 [9],[18]   $ 142 [6]  
Acquisition Date May 14, 2021 [9] May 14, 2021 [9] May 14, 2021 [6] May 14, 2021 [6]
Shares | shares 106,035 [9],[18] 106,035 [9],[18] 90,887 [6] 90,887 [6]
Drug Discovery & Development | Stealth Bio Therapeutics Corp. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[4],[6]     $ 158  
Total investments at fair value [4],[6]     $ 0  
Acquisition Date [6]     Jun. 30, 2017 Jun. 30, 2017
Shares | shares [4],[6]     500,000 500,000
Drug Discovery & Development | Seres Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-10 2024-10 2023-11 2023-11
Investment Interest Rate Floor 9.65% [7] 9.65% [7] 9.65% [12] 9.65% [12]
Principal Amount $ 37,500 [17],[18]   $ 24,051  
Investment cost 38,638 [2],[17],[18]   24,777 [1]  
Total investments at fair value $ 38,816 [17],[18]   $ 25,183  
Drug Discovery & Development | Seres Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 4.98% [7] 4.98% [7] 4.85% [12] 4.85% [12]
Drug Discovery & Development | Seres Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.40% [7] 6.40% [7] 4.40% [12] 4.40% [12]
Drug Discovery & Development | Syndax Pharmaceutics Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-04 2024-04
Investment Interest Rate Floor [12]     9.25% 9.25%
Principal Amount [3],[32]     $ 20,000  
Investment cost [1],[3],[32]     20,646  
Total investments at fair value [3],[32]     $ 20,653  
Drug Discovery & Development | Syndax Pharmaceutics Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     4.99% 4.99%
Drug Discovery & Development | Syndax Pharmaceutics Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     6.00% 6.00%
Drug Discovery & Development | TG Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-01 2026-01 2026-01 2026-01
Investment Interest Rate Floor 5.40% [7] 5.40% [7] 5.40% [12] 5.40% [12]
Investment Interest Rate Paid in Kind 3.45% [7] 3.45% [7] 3.45% [12] 3.45% [12]
Principal Amount $ 47,983 [11],[13],[18],[23]   $ 51,450 [4]  
Investment cost 47,889 [2],[11],[13],[18],[23]   50,470 [1],[4]  
Total investments at fair value $ 48,649 [11],[13],[18],[23]   $ 50,470 [4]  
Drug Discovery & Development | TG Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 5.95% [7] 5.95% [7] 5.95% [12] 5.95% [12]
Drug Discovery & Development | TG Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 2.15% [7] 2.15% [7] 2.15% [12] 2.15% [12]
Drug Discovery & Development | TG Therapeutics, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,033 [2],[9],[18],[23]   $ 1,033 [1],[4],[6],[32]  
Total investments at fair value $ 1,084 [9],[18],[23]   $ 2,172 [4],[6],[32]  
Acquisition Date Feb. 28, 2019 [9] Feb. 28, 2019 [9] Feb. 28, 2019 [6] Feb. 28, 2019 [6]
Shares | shares 231,613 [9],[18],[23] 231,613 [9],[18],[23] 231,613 [4],[6],[32] 231,613 [4],[6],[32]
Drug Discovery & Development | Uni Qure B V [Member] | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-12 2025-12 2025-12 2025-12
Investment Interest Rate Floor 7.95% [7] 7.95% [7] 7.95% [12] 7.95% [12]
Principal Amount $ 70,000 [13],[18],[19],[23],[24]   $ 77,500 [4],[5],[15],[21],[32]  
Investment cost 72,329 [2],[13],[18],[19],[23],[24]   78,755 [1],[4],[5],[15],[21],[32]  
Total investments at fair value $ 73,019 [13],[18],[19],[23],[24]   $ 78,755 [4],[5],[15],[21],[32]  
Drug Discovery & Development | Uni Qure B V [Member] | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 7.28% [7] 7.28% [7] 7.28% [12] 7.28% [12]
Drug Discovery & Development | Uni Qure B V [Member] | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 4.70% [7] 4.70% [7] 4.70% [12] 4.70% [12]
Drug Discovery & Development | Uni Qure B V [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 332 [2],[9],[19],[23],[24]   $ 332 [1],[4],[5],[6],[21]  
Total investments at fair value $ 389 [9],[19],[23],[24]   $ 356 [4],[5],[6],[21]  
Acquisition Date Jan. 31, 2019 [9] Jan. 31, 2019 [9] Jan. 31, 2019 [6] Jan. 31, 2019 [6]
Shares | shares 17,175 [9],[19],[23],[24] 17,175 [9],[19],[23],[24] 17,175 [4],[5],[6],[21] 17,175 [4],[5],[6],[21]
Drug Discovery & Development | Unity Biotechnology Inc | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-08 2024-08 2024-08 2024-08
Investment Interest Rate Floor 9.35% [7] 9.35% [7] 9.35% [12] 9.35% [12]
Principal Amount $ 20,000 [17]   $ 22,701 [30]  
Investment cost 21,079 [2],[17]   23,293 [1],[30]  
Total investments at fair value $ 20,967 [17]   $ 23,627 [30]  
Drug Discovery & Development | Unity Biotechnology Inc | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 6.25% [7] 6.25% [7] 6.25% [12] 6.25% [12]
Drug Discovery & Development | Unity Biotechnology Inc | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.10% [7] 6.10% [7] 6.10% [12] 6.10% [12]
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-05 2024-05 2024-05 2024-05
Investment Interest Rate Floor 9.70% [7] 9.70% [7] 9.70% [12] 9.70% [12]
Principal Amount $ 8,146 [13],[17]   $ 11,500 [15]  
Investment cost 8,416 [2],[13],[17]   11,547 [1],[15]  
Total investments at fair value $ 8,410 [13],[17]   $ 11,492 [15]  
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 3.85% [7] 3.85% [7] 3.85% [12] 3.85% [12]
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.45% [7] 6.45% [7] 6.45% [12] 6.45% [12]
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Warrant Investment | Common Units        
Investment Holdings [Line Items]        
Investment cost $ 256 [2]   $ 256 [1]  
Total investments at fair value     $ 441  
Acquisition Date [6]     Jun. 15, 2020 Jun. 15, 2020
Shares | shares     102,216 102,216
Drug Discovery & Development | Valo Health L L C P K Integral Health Holdings L L C [Member] | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Total investments at fair value $ 127      
Acquisition Date [9] Jun. 15, 2020 Jun. 15, 2020    
Shares | shares 102,216 102,216    
Drug Discovery & Development | X Four Pharmaceuticals Inc | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-07 2024-07 2024-07 2024-07
Investment Interest Rate Floor 8.75% [7] 8.75% [7] 8.75% [12] 8.75% [12]
Principal Amount $ 32,500 [13],[17],[18]   $ 32,500 [15],[32]  
Investment cost 33,705 [2],[13],[17],[18]   34,140 [1],[15],[32]  
Total investments at fair value $ 33,700 [13],[17],[18]   $ 34,085 [15],[32]  
Drug Discovery & Development | X Four Pharmaceuticals Inc | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 8.80% [7] 8.80% [7] 8.80% [12] 8.80% [12]
Drug Discovery & Development | X Four Pharmaceuticals Inc | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 3.75% [7] 3.75% [7] 3.75% [12] 3.75% [12]
Drug Discovery & Development | X Four Pharmaceuticals Inc | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 2,945 [2],[9]   $ 1,641 [1],[6]  
Total investments at fair value $ 1,555 [9]   $ 454 [6]  
Acquisition Date Nov. 26, 2019 [9] Nov. 26, 2019 [9] Nov. 26, 2019 [6] Nov. 26, 2019 [6]
Shares | shares 1,566,064 [9] 1,566,064 [9] 198,277 [6] 198,277 [6]
Drug Discovery & Development | X Four Pharmaceuticals Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 510 [2],[9]   $ 673 [1],[6]  
Total investments at fair value $ 281 [9]   $ 2 [6]  
Acquisition Date Dec. 09, 2022 [9] Dec. 09, 2022 [9] Mar. 18, 2019 [6] Mar. 18, 2019 [6]
Shares | shares 1,392,787 [9] 1,392,787 [9] 108,334 [6] 108,334 [6]
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-01 2024-01
Investment Interest Rate Floor [12]     8.75% 8.75%
Principal Amount     $ 12,732  
Investment cost [1]     13,256  
Total investments at fair value     $ 13,187  
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     5.92% 5.92%
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     4.00% 4.00%
Drug Discovery & Development | Yumanity Therapeutics, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 110  
Total investments at fair value [6]     $ 3  
Acquisition Date [6]     Dec. 20, 2019 Dec. 20, 2019
Shares | shares [6]     15,414 15,414
Drug Discovery & Development | Finch Therapeutics Group, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-11 2026-11    
Investment Basis Spread Variable Rate [7] 7.55% 7.55%    
Principal Amount $ 15,000      
Investment cost [2] 15,012      
Total investments at fair value $ 13,940      
Drug Discovery & Development | Finch Therapeutics Group, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 5.50% 5.50%    
Drug Discovery & Development | Finch Therapeutics Group, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 8.80% 8.80%    
Drug Discovery & Development | Finch Therapeutics Group, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.05% 4.05%    
Drug Discovery & Development | Viridian Therapeutics Inc | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-10 2026-10    
Investment Interest Rate Floor [7] 7.45% 7.45%    
Principal Amount [8],[17],[23] $ 2,000      
Investment cost [2],[8],[17],[23] 2,012      
Total investments at fair value [8],[17],[23] $ 1,934      
Drug Discovery & Development | Viridian Therapeutics Inc | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.76% 4.76%    
Drug Discovery & Development | Viridian Therapeutics Inc | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 8.95% 8.95%    
Drug Discovery & Development | Viridian Therapeutics Inc | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.20% 4.20%    
Electronics & Computer Hardware        
Investment Holdings [Line Items]        
Total investments at fair value $ 21,517   $ 1,040  
Electronics & Computer Hardware | Debt Investments        
Investment Holdings [Line Items]        
Investment cost [2] 18,171      
Total investments at fair value 18,723      
Electronics & Computer Hardware | Equity        
Investment Holdings [Line Items]        
Investment cost [2] 2,150      
Total investments at fair value 1,521      
Electronics & Computer Hardware | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 692 [2]   658 [1]  
Total investments at fair value 1,273   1,040  
Electronics & Computer Hardware | Locus Robotics Corp. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] 34      
Total investments at fair value $ 212      
Acquisition Date [9] Jun. 21, 2022 Jun. 21, 2022    
Shares | shares 8,511 8,511    
Electronics & Computer Hardware | 908 Devices, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 101 [2],[9]   101 [1],[6]  
Total investments at fair value $ 86 [9]   $ 618 [6]  
Acquisition Date Mar. 15, 2017 [9] Mar. 15, 2017 [9] Mar. 15, 2017 [6] Mar. 15, 2017 [6]
Shares | shares 49,078 [9] 49,078 [9] 49,078 [6] 49,078 [6]
Electronics & Computer Hardware | Skydio, Inc. | Equity | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost [2] $ 1,500      
Total investments at fair value $ 915      
Acquisition Date [9] Mar. 08, 2022 Mar. 08, 2022    
Shares | shares 248,900 248,900    
Electronics & Computer Hardware | Skydio, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 557 [2]   $ 557 [1]  
Total investments at fair value $ 975   $ 422  
Acquisition Date Nov. 08, 2021 [9] Nov. 08, 2021 [9] Nov. 08, 2021 [6] Nov. 08, 2021 [6]
Shares | shares 622,255 622,255 124,451 124,451
Electronics & Computer Hardware | I N M O B I Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Total investments at fair value [4]     $ 0  
Electronics & Computer Hardware | Locus Robotics Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-06 2026-06    
Investment Interest Rate Floor [7] 8.00% 8.00%    
Principal Amount [10] $ 18,281      
Investment cost [2],[10] 18,171      
Total investments at fair value [10] $ 18,723      
Electronics & Computer Hardware | Locus Robotics Corporation | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 1.00% 1.00%    
Electronics & Computer Hardware | Locus Robotics Corporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.50% 4.50%    
Electronics & Computer Hardware | Locus Robotics Corporation | Equity | Preferred Series F        
Investment Holdings [Line Items]        
Investment cost [2] $ 650      
Total investments at fair value $ 606      
Acquisition Date [9] Nov. 17, 2022 Nov. 17, 2022    
Shares | shares 15,116 15,116    
Healthcare Services Other        
Investment Holdings [Line Items]        
Total investments at fair value $ 198,763   121,003  
Healthcare Services Other | Debt Investments        
Investment Holdings [Line Items]        
Investment cost 196,342 [2]   113,724 [1]  
Total investments at fair value 195,855   113,639  
Healthcare Services Other | Equity        
Investment Holdings [Line Items]        
Investment cost 6,781 [2]   6,781 [1]  
Total investments at fair value 2,894   7,364  
Healthcare Services Other | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [2] 114      
Total investments at fair value 14      
Healthcare Services Other | Vida Health, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] 114      
Total investments at fair value $ 14      
Acquisition Date [9] Mar. 28, 2022 Mar. 28, 2022    
Shares | shares 100,618 100,618    
Healthcare Services Other | Oak Street Health, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-10 2027-10    
Investment Interest Rate Floor [7] 7.95% 7.95%    
Investment Interest Rate Paid in Kind [7] 1.00% 1.00%    
Principal Amount [8],[11],[23] $ 33,808      
Investment cost [2],[8],[11],[23] 33,651      
Total investments at fair value [8],[11],[23] $ 33,651      
Healthcare Services Other | Oak Street Health, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.95% 4.95%    
Healthcare Services Other | Oak Street Health, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 9.45% 9.45%    
Healthcare Services Other | Oak Street Health, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 2.45% 2.45%    
Healthcare Services Other | 23andMe, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 5,094 [2],[9]   5,094 [1],[6]  
Total investments at fair value $ 1,784 [9]   $ 5,500 [6]  
Acquisition Date Mar. 11, 2019 [9] Mar. 11, 2019 [9] Mar. 11, 2019 [6] Mar. 11, 2019 [6]
Shares | shares 825,732 [9] 825,732 [9] 825,732 [6] 825,732 [6]
Healthcare Services Other | Better Therapeutics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-08 2025-08 2025-08 2025-08
Investment Interest Rate Floor 8.95% [7] 8.95% [7] 8.95% [12] 8.95% [12]
Principal Amount $ 12,000 [25]   $ 8,000 [3],[31]  
Investment cost 12,162 [2],[25]   7,966 [1],[3],[31]  
Total investments at fair value $ 12,053 [25]   $ 7,966 [3],[31]  
Healthcare Services Other | Better Therapeutics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 5.95% [7] 5.95% [7] 5.95% [12] 5.95% [12]
Healthcare Services Other | Better Therapeutics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.70% [7] 5.70% [7] 5.70% [12] 5.70% [12]
Healthcare Services Other | Blue Sprig Pediatrics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-11 2026-11 2026-11 2026-11
Investment Interest Rate Floor 6.00% [7] 6.00% [7] 6.00% [12] 6.00% [12]
Investment Interest Rate Paid in Kind 4.45% [7] 4.45% [7] 4.45% [12] 4.45% [12]
Principal Amount $ 51,480 [11],[13],[17]   $ 25,022 [3],[20]  
Investment cost 50,813 [2],[11],[13],[17]   24,653 [1],[3],[20]  
Total investments at fair value $ 49,732 [11],[13],[17]   $ 24,653 [3],[20]  
Healthcare Services Other | Blue Sprig Pediatrics, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.00% [7] 5.00% [7] 5.00% [12] 5.00% [12]
Healthcare Services Other | Carbon Health Technologies, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-03 2025-03 2025-03 2025-03
Investment Interest Rate Floor 8.85% [7] 8.85% [7] 8.85% [12] 8.85% [12]
Principal Amount $ 46,125 [10],[13],[17]   $ 46,125 [3],[22]  
Investment cost 46,552 [2],[10],[13],[17]   45,964 [1],[3],[22]  
Total investments at fair value $ 46,548 [10],[13],[17]   $ 45,964 [3],[22]  
Healthcare Services Other | Carbon Health Technologies, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 4.61% [7] 4.61% [7] 4.61% [12] 4.61% [12]
Healthcare Services Other | Carbon Health Technologies, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.60% [7] 5.60% [7] 5.60% [12] 5.60% [12]
Healthcare Services Other | Carbon Health Technologies, Inc. | Equity | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost $ 1,687 [2]   $ 1,687 [1]  
Total investments at fair value $ 1,110   $ 1,864  
Acquisition Date Mar. 30, 2021 [9] Mar. 30, 2021 [9] Mar. 30, 2021 [6] Mar. 30, 2021 [6]
Shares | shares 217,880 217,880 217,880 217,880
Healthcare Services Other | Equality Health, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-02 2026-02 2026-02 2026-02
Investment Interest Rate Floor 9.50% [7] 9.50% [7] 9.50% [12] 9.50% [12]
Investment Interest Rate Paid in Kind 1.55% [7] 1.55% [7] 1.55% [12] 1.55% [12]
Principal Amount $ 53,587 [11],[18]   $ 35,444 [3],[20],[32]  
Investment cost 53,164 [2],[11],[18]   35,141 [1],[3],[20],[32]  
Total investments at fair value $ 53,871 [11],[18]   $ 35,056 [3],[20],[32]  
Healthcare Services Other | Equality Health, LLC | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.25% [7] 6.25% [7] 6.25% [12] 6.25% [12]
Information Services        
Investment Holdings [Line Items]        
Total investments at fair value $ 60,759   $ 74,417  
Information Services | Debt Investments        
Investment Holdings [Line Items]        
Investment cost 52,619 [2]   64,773 [1]  
Total investments at fair value 52,075   64,446  
Information Services | Equity        
Investment Holdings [Line Items]        
Investment cost 4,440 [2]   4,440 [1]  
Total investments at fair value 8,175   9,414  
Information Services | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 680 [2]   645 [1]  
Total investments at fair value $ 509   557  
Information Services | Signal Media Limited | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-06 2025-06    
Investment Interest Rate Floor [7] 9.00% 9.00%    
Principal Amount [8],[23],[24] $ 750      
Investment cost [2],[8],[23],[24] 742      
Total investments at fair value [8],[23],[24] $ 738      
Information Services | Signal Media Limited | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.45% 3.45%    
Information Services | Signal Media Limited | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 12.00% 12.00%    
Information Services | Signal Media Limited | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.50% 5.50%    
Information Services | Signal Media Limited | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[23],[24] $ 35      
Total investments at fair value [23],[24] $ 15      
Acquisition Date [9] Jun. 29, 2022 Jun. 29, 2022    
Shares | shares [23],[24] 94,857 94,857    
Information Services | NetBase Solutions, Inc. | Warrant Investment | Preferred Series 1        
Investment Holdings [Line Items]        
Investment cost $ 356 [2]   356 [1]  
Total investments at fair value $ 380   $ 418  
Acquisition Date Aug. 22, 2017 [9] Aug. 22, 2017 [9] Aug. 22, 2017 [6] Aug. 22, 2017 [6]
Shares | shares 60,000 60,000 60,000 60,000
Information Services | Planet Labs, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 615 [2],[9]   $ 615 [1],[6]  
Total investments at fair value $ 2,383 [9]   $ 3,369 [6]  
Acquisition Date Jun. 21, 2019 [9] Jun. 21, 2019 [9] Jun. 21, 2019 [6] Jun. 21, 2019 [6]
Shares | shares 547,880 [9] 547,880 [9] 547,880 [6] 547,880 [6]
Information Services | Zeta Global Corp. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 0 [2],[9]   $ 0 [6],[34]  
Total investments at fair value $ 2,417 [9]   $ 2,220 [6],[34]  
Acquisition Date Nov. 20, 2007 [9] Nov. 20, 2007 [9] Nov. 20, 2007 [6] Nov. 20, 2007 [6]
Shares | shares 295,861 [9] 295,861 [9] 295,861 [6],[34] 295,861 [6],[34]
Information Services | Capella Space Corp. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-11 2025-11 2024-11 2024-11
Investment Interest Rate Floor 8.25% [7] 8.25% [7] 8.25% [12] 8.25% [12]
Investment Interest Rate Paid in Kind 1.10% [7] 1.10% [7] 1.10% [12] 1.10% [12]
Principal Amount $ 20,250 [10],[11],[25]   $ 20,025 [20],[22],[31]  
Investment cost 20,506 [2],[10],[11],[25]   19,751 [1],[20],[22],[31]  
Total investments at fair value $ 20,574 [10],[11],[25]   $ 19,424 [20],[22],[31]  
Information Services | Capella Space Corp. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 7.00% [7] 7.00% [7] 4.00% [12] 4.00% [12]
Information Services | Capella Space Corp. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.00% [7] 5.00% [7] 5.00% [12] 5.00% [12]
Information Services | Capella Space Corp. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 207 [2],[25]   $ 207 [1],[31]  
Total investments at fair value $ 114 [25]   $ 139 [31]  
Acquisition Date Oct. 21, 2021 [9] Oct. 21, 2021 [9] Oct. 21, 2021 [6] Oct. 21, 2021 [6]
Shares | shares 176,200 [25] 176,200 [25] 176,200 [31] 176,200 [31]
Information Services | I N M O B I Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 82 [2],[23],[24]   $ 82 [1],[4]  
Total investments at fair value [23],[24] $ 0      
Acquisition Date Nov. 19, 2014 [9] Nov. 19, 2014 [9] Nov. 19, 2014 [6] Nov. 19, 2014 [6]
Shares | shares 65,587 [23],[24] 65,587 [23],[24] 65,587 [4] 65,587 [4]
Information Services | Yipit, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-09 2026-09 2026-09 2026-09
Investment Interest Rate Floor 10.08% [7] 10.08% [7] 10.08% [12] 10.08% [12]
Principal Amount $ 31,875 [8],[14]   $ 45,900 [3],[16]  
Investment cost 31,371 [2],[8],[14]   45,022 [1],[3],[16]  
Total investments at fair value $ 30,763 [8],[14]   $ 45,022 [3],[16]  
Information Services | Yipit, LLC | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     9.08% 9.08%
Information Services | Yipit, LLC | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 9.08% 9.08%    
Information Services | Yipit, LLC | Equity | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost $ 3,825 [2]   $ 3,825 [1]  
Total investments at fair value $ 3,375   $ 3,825  
Acquisition Date Dec. 30, 2021 [9] Dec. 30, 2021 [9] Dec. 30, 2021 [6] Dec. 30, 2021 [6]
Shares | shares 41,021 41,021 41,021 41,021
Consumer & Business Services        
Investment Holdings [Line Items]        
Total investments at fair value $ 439,384   $ 395,506  
Consumer & Business Services | Debt Investments        
Investment Holdings [Line Items]        
Investment cost [1]     363,165  
Total investments at fair value     349,963  
Consumer & Business Services | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     22,151  
Total investments at fair value     35,331  
Consumer & Business Services | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [1]     4,992  
Total investments at fair value     10,212  
Consumer & Business Services | Xometry, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     47  
Total investments at fair value [6]     $ 3,038  
Acquisition Date [6]     May 09, 2018 May 09, 2018
Shares | shares [6]     87,784 87,784
Consumer & Business Services | The Faction Group LLC | Warrant Investment | Preferred Series AA        
Investment Holdings [Line Items]        
Investment cost [1]     $ 234  
Total investments at fair value     $ 650  
Acquisition Date [6]     Nov. 03, 2014 Nov. 03, 2014
Shares | shares     8,076 8,076
Consumer & Business Services | Snagajobcom Inc | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [1]     $ 860  
Total investments at fair value     $ 382  
Shares | shares     3,611,537 3,611,537
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [1],[32]     $ 782  
Total investments at fair value [32]     $ 171  
Acquisition Date [6]     Jun. 30, 2016 Jun. 30, 2016
Shares | shares [32]     1,800,000 1,800,000
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [1],[32]     $ 62  
Total investments at fair value [32]     $ 90  
Acquisition Date [6]     Aug. 01, 2018 Aug. 01, 2018
Shares | shares [32]     1,211,537 1,211,537
Consumer & Business Services | Snagajobcom Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[32]     $ 16  
Total investments at fair value [32]     $ 121  
Acquisition Date [6]     Apr. 20, 2020 Apr. 20, 2020
Shares | shares [32]     600,000 600,000
Consumer & Business Services | Tapjoy, Inc. | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [1]     $ 317  
Total investments at fair value     $ 443  
Acquisition Date [6]     Jul. 01, 2014 Jul. 01, 2014
Shares | shares     748,670 748,670
Consumer & Business Services | ShareThis, Inc. | Warrant Investment | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost [1]     $ 547  
Total investments at fair value     $ 0  
Acquisition Date [6]     Dec. 14, 2012 Dec. 14, 2012
Shares | shares     493,502 493,502
Consumer & Business Services | Logic Source | Warrant Investment | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost [1]     $ 30  
Total investments at fair value     $ 210  
Acquisition Date [6]     Mar. 21, 2016 Mar. 21, 2016
Shares | shares     79,625 79,625
Consumer & Business Services | RumbleON, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 88  
Total investments at fair value [6]     $ 33  
Acquisition Date [6]     Apr. 30, 2018 Apr. 30, 2018
Shares | shares [6]     5,139 5,139
Consumer & Business Services | Lendio, Inc. | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [1]     $ 39  
Total investments at fair value     $ 84  
Acquisition Date [6]     Mar. 29, 2019 Mar. 29, 2019
Shares | shares     127,032 127,032
Consumer & Business Services | Cloudpay, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [1],[4],[5]     $ 54  
Total investments at fair value [4],[5]     $ 348  
Acquisition Date [6]     Apr. 10, 2018 Apr. 10, 2018
Shares | shares [4],[5]     6,763 6,763
Consumer & Business Services | Landing Holdings Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[31]     $ 116  
Total investments at fair value [31]     $ 141  
Acquisition Date [6]     Mar. 12, 2021 Mar. 12, 2021
Shares | shares [31]     11,806 11,806
Consumer & Business Services | First Insight, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [1]     $ 96  
Total investments at fair value     $ 105  
Acquisition Date [6]     May 10, 2018 May 10, 2018
Shares | shares     75,917 75,917
Consumer & Business Services | Aria Systems, Inc. | Warrant Investment | Preferred Series G        
Investment Holdings [Line Items]        
Investment cost [1]     $ 74  
Total investments at fair value     $ 0  
Acquisition Date [6]     May 22, 2015 May 22, 2015
Shares | shares     231,535 231,535
Consumer & Business Services | Lyft Inc | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 5,263  
Total investments at fair value [6]     $ 4,305  
Acquisition Date [6]     Dec. 26, 2018 Dec. 26, 2018
Shares | shares [6]     100,738 100,738
Consumer & Business Services | Uber Technologies, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 318  
Total investments at fair value [6]     $ 1,383  
Acquisition Date [6]     Dec. 01, 2020 Dec. 01, 2020
Shares | shares [6]     32,991 32,991
Consumer & Business Services | Nerdy Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 1,000  
Total investments at fair value [6]     $ 450  
Acquisition Date [6]     Sep. 17, 2021 Sep. 17, 2021
Shares | shares [6]     100,000 100,000
Consumer & Business Services | TFG Holding, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 89  
Total investments at fair value     $ 216  
Acquisition Date [6]     Apr. 30, 2010 Apr. 30, 2010
Shares | shares     42,989 42,989
Consumer & Business Services | DoorDash, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 945  
Total investments at fair value [6]     $ 12,209  
Acquisition Date [6]     Dec. 20, 2018 Dec. 20, 2018
Shares | shares [6]     81,996 81,996
Consumer & Business Services | Savage X Holding, LLC | Equity | Class A Units        
Investment Holdings [Line Items]        
Investment cost [1]     $ 13  
Total investments at fair value     $ 71  
Acquisition Date [6]     Apr. 30, 2010 Apr. 30, 2010
Shares | shares     42,137 42,137
Consumer & Business Services | Nextdoor.com, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6],[34]     $ 4,854  
Total investments at fair value [6],[34]     $ 6,624  
Acquisition Date [6]     Aug. 01, 2018 Aug. 01, 2018
Shares | shares [6],[34]     1,019,255 1,019,255
Consumer & Business Services | OfferUp, Inc. | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     $ 2,295  
Total investments at fair value     $ 2,471  
Shares | shares     394,790 394,790
Consumer & Business Services | OfferUp, Inc. | Equity | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [1]     $ 1,663  
Total investments at fair value     $ 1,791  
Acquisition Date [6]     Oct. 25, 2016 Oct. 25, 2016
Shares | shares     286,080 286,080
Consumer & Business Services | OfferUp, Inc. One | Equity | Preferred Series A-1        
Investment Holdings [Line Items]        
Investment cost [1]     $ 632  
Total investments at fair value     $ 680  
Acquisition Date [6]     Oct. 25, 2016 Oct. 25, 2016
Shares | shares     108,710 108,710
Consumer & Business Services | Oportun | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[6]     $ 577  
Total investments at fair value [6]     $ 980  
Acquisition Date [6]     Jun. 28, 2013 Jun. 28, 2013
Shares | shares [6]     48,365 48,365
Consumer & Business Services | Reischling Press, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 15  
Total investments at fair value     $ 0  
Acquisition Date [6]     Jul. 31, 2020 Jul. 31, 2020
Shares | shares     1,163 1,163
Consumer & Business Services | Brigade Group, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 93  
Total investments at fair value     $ 0  
Acquisition Date [6]     Mar. 01, 2013 Mar. 01, 2013
Shares | shares     9,023 9,023
Consumer & Business Services | Contentful Global, Inc. | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     $ 638  
Total investments at fair value     $ 1,894  
Shares | shares     149,500 149,500
Consumer & Business Services | Contentful Global, Inc. | Equity | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost [1],[4],[5]     $ 138  
Total investments at fair value [4],[5]     $ 506  
Acquisition Date [6]     Dec. 22, 2020 Dec. 22, 2020
Shares | shares [4],[5]     41,000 41,000
Consumer & Business Services | Contentful Global, Inc. One | Equity | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [1],[4],[5]     $ 500  
Total investments at fair value [4],[5]     $ 1,388  
Acquisition Date [6]     Nov. 20, 2018 Nov. 20, 2018
Shares | shares [4],[5]     108,500 108,500
Consumer & Business Services | Black Crow AI, Inc. affiliates | Equity | Preferred Series Seed        
Investment Holdings [Line Items]        
Investment cost [1],[35]     $ 1,000  
Total investments at fair value [35]     $ 1,120  
Acquisition Date [6]     Mar. 24, 2021 Mar. 24, 2021
Shares | shares [35]     872,797 872,797
Consumer & Business Services | Black Crow AI, Inc. affiliates | Equity | Preferred Stock        
Investment Holdings [Line Items]        
Investment cost [1],[36]     $ 3,000  
Total investments at fair value [36]     $ 3,000  
Acquisition Date [6]     Mar. 24, 2021 Mar. 24, 2021
Shares | shares [36]     3 3
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-08 2024-08
Investment Interest Rate Floor [12]     9.15% 9.15%
Principal Amount     $ 30,790  
Investment cost [1]     31,416  
Total investments at fair value     $ 32,248  
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     7.95% 7.95%
Consumer & Business Services | App Direct Incorporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.90% 5.90%
Consumer & Business Services | Carwow LTD | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-12 2024-12
Investment Interest Rate Floor [12]     7.95% 7.95%
Investment Interest Rate Paid in Kind [12]     1.45% 1.45%
Principal Amount | £ [4],[5],[20]       £ 21,250
Investment cost [1],[4],[5],[20]     $ 28,632  
Total investments at fair value [4],[5],[20]     $ 28,632  
Consumer & Business Services | Carwow LTD | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     4.95% 4.95%
Consumer & Business Services | Carwow LTD | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     4.70% 4.70%
Consumer & Business Services | Carwow LTD | Equity | Preferred Series D-4        
Investment Holdings [Line Items]        
Investment cost [1],[4],[5]     $ 1,151  
Total investments at fair value [4],[5]     $ 608  
Acquisition Date [6]     Dec. 15, 2021 Dec. 15, 2021
Shares | shares [4],[5]     199,742 199,742
Consumer & Business Services | Carwow LTD | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[4],[5]     $ 164  
Total investments at fair value [4],[5]     $ 160  
Acquisition Date [6]     Dec. 14, 2021 Dec. 14, 2021
Shares | shares [4],[5]     174,163 174,163
Consumer & Business Services | E Pay Policy Holdings L L C | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-12 2024-12
Investment Interest Rate Floor [12]     9.50% 9.50%
Principal Amount [3],[15]     $ 8,169  
Investment cost [1],[3],[15]     8,011  
Total investments at fair value [3],[15]     $ 7,967  
Consumer & Business Services | E Pay Policy Holdings L L C | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     8.50% 8.50%
Consumer & Business Services | Houzz, Inc. | Convertible Debt        
Investment Holdings [Line Items]        
Maturity Date     2028-05 2028-05
Investment Interest Rate Paid in Kind [12]     5.50% 5.50%
Principal Amount [20],[30]     $ 20,676  
Investment cost [1],[20],[30]     20,676  
Total investments at fair value [20],[30]     20,425  
Consumer & Business Services | Houzz, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     20  
Total investments at fair value     $ 116  
Acquisition Date [6]     Oct. 29, 2019 Oct. 29, 2019
Shares | shares     529,661 529,661
Consumer & Business Services | Interactions Corporation | Warrant Investment | Series G Three Preferred Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 204  
Total investments at fair value     $ 505  
Acquisition Date [6]     Jun. 16, 2015 Jun. 16, 2015
Shares | shares     68,187 68,187
Consumer & Business Services | Nextroll, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2022-06 2022-06
Investment Interest Rate Floor [12]     7.00% 7.00%
Investment Interest Rate Paid in Kind [12]     2.95% 2.95%
Principal Amount [20],[22],[32]     $ 21,555  
Investment cost [1],[20],[22],[32]     22,164  
Total investments at fair value [20],[22],[32]     $ 22,164  
Consumer & Business Services | Nextroll, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     3.50% 3.50%
Consumer & Business Services | Nextroll, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     3.75% 3.75%
Consumer & Business Services | Rhino Labs Incorporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-03 2024-03
Investment Interest Rate Floor [12]     8.75% 8.75%
Investment Interest Rate Paid in Kind [12]     2.25% 2.25%
Principal Amount [20],[31]     $ 16,136  
Investment cost [1],[20],[31]     15,765  
Total investments at fair value [20],[31]     $ 15,876  
Consumer & Business Services | Rhino Labs Incorporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.50% 5.50%
Consumer & Business Services | Rhino Labs Incorporation | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[31]     $ 470  
Total investments at fair value [31]     $ 77  
Acquisition Date [6]     Mar. 12, 2021 Mar. 12, 2021
Shares | shares [31]     13,106 13,106
Consumer & Business Services | R V Share Limited Liability Company | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2026-12 2026-12
Investment Interest Rate Floor [12]     6.50% 6.50%
Investment Interest Rate Paid in Kind [12]     4.00% 4.00%
Principal Amount [3],[31]     $ 15,000  
Investment cost [1],[3],[31]     14,701  
Total investments at fair value [3],[31]     $ 14,701  
Consumer & Business Services | R V Share Limited Liability Company | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.50% 5.50%
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2023-06 2023-06
Investment Interest Rate Floor [12]     10.50% 10.50%
Investment Interest Rate Paid in Kind [12]     0.50% 0.50%
Principal Amount [20]     $ 60,607  
Investment cost [1],[20]     59,983  
Total investments at fair value [20]     $ 60,316  
Consumer & Business Services | SeatGeek, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.00% 5.00%
Consumer & Business Services | SeatGeek, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 842  
Total investments at fair value     $ 1,140  
Acquisition Date [6]     Jun. 12, 2019 Jun. 12, 2019
Shares | shares     1,379,761 1,379,761
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-09 2024-09
Investment Interest Rate Floor [12]     9.38% 9.38%
Investment Interest Rate Paid in Kind [12]     1.90% 1.90%
Principal Amount [20]     $ 12,426  
Investment cost [1],[20]     12,665  
Total investments at fair value [20]     $ 12,521  
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     4.00% 4.00%
Consumer & Business Services | Skyword, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     3.88% 3.88%
Consumer & Business Services | Skyword, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [1]     $ 83  
Total investments at fair value     $ 7  
Acquisition Date [6]     Aug. 23, 2019 Aug. 23, 2019
Shares | shares     444,444 444,444
Consumer & Business Services | Tectura Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-07 2024-07
Investment Interest Rate Paid in Kind [12]     5.00% 5.00%
Principal Amount [20],[29],[37]     $ 10,680  
Investment cost [1],[20],[29],[37]     240  
Total investments at fair value [20],[29],[37]     0  
Consumer & Business Services | Tectura Corporation | Equity | Preferred Series BB        
Investment Holdings [Line Items]        
Total investments at fair value [29]     $ 0  
Acquisition Date [6]     Jun. 06, 2016 Jun. 06, 2016
Shares | shares [29]     1,000,000 1,000,000
Consumer & Business Services | Tectura Corporation | Equity | Preferred Series BB        
Investment Holdings [Line Items]        
Investment cost [29]     $ 0  
Consumer & Business Services | Tectura Corporation | Equity | Common Stock        
Investment Holdings [Line Items]        
Total investments at fair value [29]     $ 0  
Consumer & Business Services | Tectura Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-07 2024-07
Principal Amount [29],[37]     $ 8,250  
Investment Interest Rate Paid in Cash [12]     8.25% 8.25%
Investment cost [1],[29],[37]     $ 8,250  
Total investments at fair value [29],[37]     $ 8,250  
Consumer & Business Services | Tectura Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-07 2024-07
Investment Interest Rate Paid in Kind [12]     5.00% 5.00%
Principal Amount [20],[29],[37]     $ 13,023  
Investment cost [1],[20],[29],[37]     13,023  
Total investments at fair value [20],[29],[37]     19  
Consumer & Business Services | Tectura Corporation | Debt Investments        
Investment Holdings [Line Items]        
Principal Amount     31,953  
Investment cost [1]     21,513  
Total investments at fair value     8,269  
Consumer & Business Services | Tectura Corporation | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     $ 900  
Shares | shares     415,994,863 415,994,863
Consumer & Business Services | Tectura Corporation | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1],[29]     $ 900  
Acquisition Date [6]     May 23, 2018 May 23, 2018
Shares | shares [29]     414,994,863 414,994,863
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2023-09 2023-09
Investment Interest Rate Floor [12]     8.95% 8.95%
Investment Interest Rate Paid in Kind [12]     1.50% 1.50%
Principal Amount [20],[32]     $ 25,618  
Investment cost [1],[20],[32]     25,965  
Total investments at fair value [20],[32]     $ 26,372  
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     3.95% 3.95%
Consumer & Business Services | Thumbtack, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     3.45% 3.45%
Consumer & Business Services | Thumbtack, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 552  
Total investments at fair value     $ 786  
Acquisition Date [6]     May 01, 2018 May 01, 2018
Shares | shares     190,953 190,953
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2025-02 2025-02
Investment Interest Rate Floor [12]     10.25% 10.25%
Principal Amount [4],[5],[21],[22],[32]     $ 103,000  
Investment cost [1],[4],[5],[21],[22],[32]     101,674  
Total investments at fair value [4],[5],[21],[22],[32]     $ 100,472  
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     3.00% 3.00%
Consumer & Business Services | Worldremit Group Limited | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     9.25% 9.25%
Consumer & Business Services | Worldremit Group Limited | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [1]     $ 155  
Total investments at fair value     $ 1,987  
Shares | shares     79,083 79,083
Consumer & Business Services | Worldremit Group Limited | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [1],[4],[5],[21]     $ 129  
Total investments at fair value [4],[5],[21]     $ 1,962  
Acquisition Date [6]     Feb. 11, 2021 Feb. 11, 2021
Shares | shares [4],[5],[21]     77,215 77,215
Consumer & Business Services | Worldremit Group Limited One | Warrant Investment | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost [1],[4],[5],[21]     $ 26  
Total investments at fair value [4],[5],[21]     $ 25  
Acquisition Date [6]     Aug. 27, 2021 Aug. 27, 2021
Shares | shares [4],[5],[21]     1,868 1,868
Media/Content/Info        
Investment Holdings [Line Items]        
Total investments at fair value 35   $ 0  
Media/Content/Info | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 35 [2]   348 [1]  
Total investments at fair value 35   0  
Media/Content/Info | Fever Labs, Inc. | Warrant Investment | Series E One Preferred Stock        
Investment Holdings [Line Items]        
Investment cost [2] 35      
Total investments at fair value $ 35      
Acquisition Date [9] Dec. 30, 2022 Dec. 30, 2022    
Shares | shares 221,622 221,622    
Media/Content/Info | Zoom Media Group, Inc. | Warrant Investment | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [1]     348  
Total investments at fair value     $ 0  
Acquisition Date [6]     Dec. 21, 2012 Dec. 21, 2012
Shares | shares     1,204 1,204
Manufacturing Technology        
Investment Holdings [Line Items]        
Total investments at fair value $ 46,109   $ 14,995  
Manufacturing Technology | Debt Investments        
Investment Holdings [Line Items]        
Investment cost 41,568 [2]   $ 14,995 [1]  
Total investments at fair value 41,953      
Manufacturing Technology | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [2] 1,112      
Total investments at fair value 4,156      
Manufacturing Technology | Xometry, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] 47      
Total investments at fair value [9] $ 1,800      
Acquisition Date [9] May 09, 2018 May 09, 2018    
Shares | shares [9] 87,784 87,784    
Manufacturing Technology | Ouster, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-05 2026-05    
Investment Interest Rate Floor [7] 9.40% 9.40%    
Principal Amount [17],[23] $ 14,000      
Investment cost [2],[17],[23] 13,970      
Total investments at fair value [17],[23] $ 14,204      
Manufacturing Technology | Ouster, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 7.45% 7.45%    
Manufacturing Technology | Ouster, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 6.15% 6.15%    
Manufacturing Technology | Bright Machines, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-04 2025-04 2022-11 2022-11
Investment Interest Rate Floor 9.50% [7] 9.50% [7] 8.95% [12] 8.95% [12]
Principal Amount $ 11,050 [17]   $ 15,000 [22]  
Investment cost 10,832 [2],[17]   14,995 [1],[22]  
Total investments at fair value $ 10,832 [17]   $ 14,995 [22]  
Manufacturing Technology | Bright Machines, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 5.00% [7] 5.00% [7] 6.95% [12] 6.95% [12]
Manufacturing Technology | Bright Machines, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 4.00% [7] 4.00% [7] 5.70% [12] 5.70% [12]
Manufacturing Technology | Bright Machines, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 537      
Total investments at fair value $ 1,154      
Acquisition Date [9] Mar. 31, 2022 Mar. 31, 2022    
Shares | shares 392,308 392,308    
Manufacturing Technology | MacroFab, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-03 2026-03    
Investment Interest Rate Floor [7] 7.60% 7.60%    
Investment Interest Rate Paid in Kind [7] 1.25% 1.25%    
Principal Amount [8],[11] $ 17,137      
Investment cost [2],[8],[11] 16,766      
Total investments at fair value [8],[11] $ 16,917      
Manufacturing Technology | MacroFab, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.50% 4.50%    
Manufacturing Technology | MacroFab, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.35% 4.35%    
Manufacturing Technology | MacroFab, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 528      
Total investments at fair value $ 1,202      
Acquisition Date [9] Mar. 23, 2022 Mar. 23, 2022    
Shares | shares 1,111,111 1,111,111    
Semiconductors        
Investment Holdings [Line Items]        
Total investments at fair value $ 21,921   $ 22,498  
Semiconductors | Debt Investments        
Investment Holdings [Line Items]        
Investment cost 19,639 [2]   19,072 [1]  
Total investments at fair value 21,192      
Semiconductors | Equity        
Investment Holdings [Line Items]        
Investment cost [2] 160      
Total investments at fair value 205   725  
Semiconductors | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 850 [2]   850 [1]  
Total investments at fair value $ 524   $ 2,701  
Semiconductors | Fungible, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-12 2024-12 2024-12 2024-12
Investment Interest Rate Floor 8.25% [7] 8.25% [7] 8.25% [12] 8.25% [12]
Principal Amount $ 20,000 [10],[25]   $ 20,000 [22],[31]  
Investment cost 19,639 [2],[10],[25]   19,072 [1],[22],[31]  
Total investments at fair value $ 21,192 [10],[25]   $ 19,072 [22],[31]  
Semiconductors | Fungible, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 4.95% [7] 4.95% [7] 4.95% [12] 4.95% [12]
Semiconductors | Fungible, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.00% [7] 5.00% [7] 5.00% [12] 5.00% [12]
Semiconductors | Fungible, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 751 [2],[25]   $ 751 [1],[31]  
Total investments at fair value $ 0 [25]   $ 751 [31]  
Acquisition Date Dec. 16, 2021 [9] Dec. 16, 2021 [9] Dec. 16, 2021 [6] Dec. 16, 2021 [6]
Shares | shares 800,000 [25] 800,000 [25] 800,000 [31] 800,000 [31]
Semiconductors | Achronix Semiconductor Corporation [Member] | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     $ 160  
Semiconductors | Achronix Semiconductor Corporation [Member] | Equity | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost $ 160 [2]   160 [1]  
Total investments at fair value $ 205   $ 725  
Acquisition Date Jul. 01, 2011 [9] Jul. 01, 2011 [9] Jul. 01, 2011 [6] Jul. 01, 2011 [6]
Shares | shares 277,995 277,995 277,995 277,995
Semiconductors | Achronix Semiconductor Corporation [Member] | Warrant Investment | Preferred Series D-2        
Investment Holdings [Line Items]        
Investment cost $ 99 [2]   $ 99 [1]  
Total investments at fair value $ 524   $ 1,950  
Acquisition Date Jun. 26, 2015 [9] Jun. 26, 2015 [9] Jun. 26, 2015 [6] Jun. 26, 2015 [6]
Shares | shares 750,000 750,000 750,000 750,000
Software        
Investment Holdings [Line Items]        
Total investments at fair value $ 798,264   $ 585,622  
Software | Investment Funds & Vehicles [Member]        
Investment Holdings [Line Items]        
Investment cost [2] 381      
Total investments at fair value 375      
Software | Senior Secured Debt        
Investment Holdings [Line Items]        
Investment cost [2] 762,371      
Total investments at fair value 760,679      
Software | Debt Investments        
Investment Holdings [Line Items]        
Investment cost [1]     526,253  
Total investments at fair value     529,402  
Software | Equity        
Investment Holdings [Line Items]        
Investment cost 32,498 [2]   23,905 [1]  
Total investments at fair value 28,966   45,087  
Software | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 9,761 [2]   5,594 [1]  
Total investments at fair value 8,244   11,133  
Software | Fulfil Solutions, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] 325      
Total investments at fair value $ 314      
Acquisition Date [9] Jul. 29, 2022 Jul. 29, 2022    
Shares | shares 84,995 84,995    
Software | Liberty Zim CoInvest LP | Investment Funds & Vehicles [Member]        
Investment Holdings [Line Items]        
Investment cost [2],[23],[24] $ 381      
Total investments at fair value [23],[24] $ 375      
Acquisition Date [9] Jul. 21, 2022 Jul. 21, 2022    
Software | Annex Cloud | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-02 2027-02    
Investment Interest Rate Floor [7] 10.00% 10.00%    
Principal Amount [8],[17] $ 8,500      
Investment cost [2],[8],[17] 8,292      
Total investments at fair value [8],[17] $ 8,176      
Software | Annex Cloud | Senior Secured Debt | BSBY        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.99% 8.99%    
Software | Convoy, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-03 2026-03    
Investment Interest Rate Floor [7] 6.45% 6.45%    
Investment Interest Rate Paid in Kind [7] 1.95% 1.95%    
Principal Amount [10],[11],[19] $ 73,987      
Investment cost [2],[10],[11],[19] 73,060      
Total investments at fair value [10],[11],[19] $ 73,498      
Software | Convoy, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.55% 4.55%    
Software | Convoy, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.20% 3.20%    
Software | Convoy, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[19] $ 974      
Total investments at fair value [19] $ 364      
Acquisition Date [9] Mar. 30, 2022 Mar. 30, 2022    
Shares | shares [19] 165,456 165,456    
Software | Cutover, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-10 2025-10    
Investment Interest Rate Floor [7] 9.95% 9.95%    
Principal Amount [8],[18],[23],[24] $ 5,000      
Investment cost [2],[8],[18],[23],[24] 4,949      
Total investments at fair value [8],[18],[23],[24] $ 4,949      
Software | Cutover, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.95% 4.95%    
Software | Cutover, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.20% 5.20%    
Software | Cutover, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[18],[23],[24] $ 26      
Total investments at fair value [18],[23],[24] $ 19      
Acquisition Date [9] Sep. 21, 2022 Sep. 21, 2022    
Shares | shares [18],[23],[24] 102,898 102,898    
Software | Constructor.io Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-07 2027-07    
Investment Interest Rate Floor [7] 9.44% 9.44%    
Principal Amount [8],[14] $ 4,688      
Investment cost [2],[8],[14] 4,573      
Total investments at fair value [8],[14] $ 4,573      
Software | Constructor.io Corporation | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.44% 8.44%    
Software | Automation Any Where Inc | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-09 2027-09    
Investment Interest Rate Floor [7] 9.00% 9.00%    
Principal Amount [8],[10],[13] $ 19,600      
Investment cost [2],[8],[10],[13] 19,059      
Total investments at fair value [8],[10],[13] $ 19,059      
Software | Automation Any Where Inc | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 2.50% 2.50%    
Software | Automation Any Where Inc | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.25% 4.25%    
Software | Automation Any Where Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 448      
Total investments at fair value $ 365      
Acquisition Date [9] Sep. 23, 2022 Sep. 23, 2022    
Shares | shares 254,778 254,778    
Software | Catchpoint Systems, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-06 2026-06    
Investment Interest Rate Floor [7] 9.76% 9.76%    
Principal Amount [14] $ 10,175      
Investment cost [2],[14] 9,980      
Total investments at fair value [14] $ 9,996      
Software | Catchpoint Systems, Inc. | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.86% 8.86%    
Software | Alchemer LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2028-05 2028-05    
Investment Interest Rate Floor [7] 8.89% 8.89%    
Principal Amount [8],[14] $ 20,463      
Investment cost [2],[8],[14] 19,999      
Total investments at fair value [8],[14] $ 20,123      
Software | Alchemer LLC | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 7.89% 7.89%    
Software | Ceros, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-09 2026-09    
Investment Interest Rate Floor [7] 10.67% 10.67%    
Principal Amount [8],[14] $ 21,445      
Investment cost [2],[8],[14] 21,003      
Total investments at fair value [8],[14] $ 21,050      
Software | Ceros, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 9.67% 9.67%    
Software | Zero Fox Inc | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9],[38] $ 101      
Total investments at fair value [9],[38] $ 1,382      
Acquisition Date [9] May 07, 2020 May 07, 2020    
Shares | shares [9],[38] 289,992 289,992    
Software | Zero Fox Inc | Warrant Investment | Preferred Series C-1        
Investment Holdings [Line Items]        
Investment cost [1]     101  
Total investments at fair value     $ 603  
Acquisition Date [6]     May 07, 2020 May 07, 2020
Shares | shares     648,350 648,350
Software | Sign Post Inc | Warrant Investment | Series Junior 1 Preferred        
Investment Holdings [Line Items]        
Investment cost $ 314 [2]   $ 314 [1]  
Total investments at fair value   $ 0  
Acquisition Date Jan. 13, 2016 [9] Jan. 13, 2016 [9] Jan. 13, 2016 [6] Jan. 13, 2016 [6]
Shares | shares 474,019 474,019 474,019 474,019
Software | Rapid Miner Inc | Warrant Investment | Preferred Series C-1        
Investment Holdings [Line Items]        
Investment cost [1]     $ 24  
Total investments at fair value     $ 54  
Acquisition Date [6]     Nov. 28, 2017 Nov. 28, 2017
Shares | shares     4,982 4,982
Software | Poplicus Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 0 [2]   $ 0 [1]  
Total investments at fair value   $ 0  
Acquisition Date May 28, 2014 [9] May 28, 2014 [9] May 28, 2014 [6] May 28, 2014 [6]
Shares | shares 132,168 132,168 132,168 132,168
Software | Fuze, Inc. | Warrant Investment | Preferred Series F        
Investment Holdings [Line Items]        
Investment cost [1]     $ 89  
Total investments at fair value     $ 0  
Acquisition Date [6]     Jun. 30, 2017 Jun. 30, 2017
Shares | shares     256,158 256,158
Software | Cloudian Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 71 [2]   $ 71 [1]  
Total investments at fair value $ 14   $ 33  
Acquisition Date Nov. 06, 2018 [9] Nov. 06, 2018 [9] Nov. 06, 2018 [6] Nov. 06, 2018 [6]
Shares | shares 477,454 477,454 477,454 477,454
Software | D N Anexus Inc | Warrant Investment | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost $ 97 [2]   $ 97 [1]  
Total investments at fair value $ 131   $ 102  
Acquisition Date Mar. 21, 2014 [9] Mar. 21, 2014 [9] Mar. 21, 2014 [6] Mar. 21, 2014 [6]
Shares | shares 909,091 909,091 909,091 909,091
Software | Dronedeploy Incorporation | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 278      
Total investments at fair value $ 300      
Acquisition Date [9] Jun. 30, 2022 Jun. 30, 2022    
Shares | shares 95,911 95,911    
Software | Evernote Corporation | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 107 [2]   $ 106 [1]  
Total investments at fair value $ 6   $ 65  
Acquisition Date Sep. 30, 2016 [9] Sep. 30, 2016 [9] Sep. 30, 2016 [6] Sep. 30, 2016 [6]
Shares | shares 62,500 62,500 62,500 62,500
Software | Couchbase Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 462 [2],[9]   $ 462 [1],[6],[34]  
Total investments at fair value $ 488 [9]   $ 1,343 [6],[34]  
Acquisition Date Apr. 25, 2019 [9] Apr. 25, 2019 [9] Apr. 25, 2019 [6] Apr. 25, 2019 [6]
Shares | shares 105,350 [9] 105,350 [9] 105,350 [6],[34] 105,350 [6],[34]
Software | Bitsight Technologies Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 284 [2]   $ 284 [1]  
Total investments at fair value $ 398   $ 1,272  
Acquisition Date Nov. 18, 2020 [9] Nov. 18, 2020 [9] Nov. 18, 2020 [6] Nov. 18, 2020 [6]
Shares | shares 29,691 29,691 29,691 29,691
Software | The Faction Group LLC | Warrant Investment | Preferred Series AA        
Investment Holdings [Line Items]        
Investment cost [2] $ 234      
Total investments at fair value $ 436      
Acquisition Date [9] Nov. 03, 2014 Nov. 03, 2014    
Shares | shares 8,076 8,076    
Software | Logic Source | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-07 2027-07    
Investment Interest Rate Floor [7] 9.93% 9.93%    
Principal Amount [8] $ 13,300      
Investment cost [2],[8] 13,028      
Total investments at fair value [8] $ 13,028      
Software | Logic Source | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.93% 8.93%    
Software | Cloudpay, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [2],[23],[24] $ 54      
Total investments at fair value [23],[24] $ 400      
Acquisition Date [9] Apr. 10, 2018 Apr. 10, 2018    
Shares | shares [23],[24] 6,763 6,763    
Software | First Insight, Inc. | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost [2] $ 96      
Total investments at fair value $ 39      
Acquisition Date [9] May 10, 2018 May 10, 2018    
Shares | shares 75,917 75,917    
Software | Aria Systems, Inc. | Warrant Investment | Preferred Series G        
Investment Holdings [Line Items]        
Investment cost [2] $ 74      
Total investments at fair value      
Acquisition Date [9] May 22, 2015 May 22, 2015    
Shares | shares 231,535 231,535    
Software | Babel Street | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-12 2027-12    
Investment Interest Rate Floor [7] 8.89% 8.89%    
Principal Amount [8],[14],[25] $ 45,000      
Investment cost [2],[8],[14],[25] 43,801      
Total investments at fair value [8],[14],[25] $ 43,801      
Software | Babel Street | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 7.89% 7.89%    
Software | Nextdoor.com, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] $ 4,854      
Total investments at fair value [9] $ 2,100      
Acquisition Date [9] Aug. 01, 2018 Aug. 01, 2018    
Shares | shares [9] 1,019,255 1,019,255    
Software | Contentful Global, Inc. | Equity        
Investment Holdings [Line Items]        
Investment cost [2] $ 638      
Total investments at fair value $ 990      
Shares | shares 149,500 149,500    
Software | Contentful Global, Inc. | Equity | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [2],[23],[24] $ 500      
Total investments at fair value [23],[24] $ 732      
Acquisition Date [9] Nov. 20, 2018 Nov. 20, 2018    
Shares | shares [23],[24] 108,500 108,500    
Software | Contentful Global, Inc. | Equity | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost [2],[23],[24] $ 138      
Total investments at fair value [23],[24] $ 258      
Acquisition Date [9] Dec. 22, 2020 Dec. 22, 2020    
Shares | shares [23],[24] 41,000 41,000    
Software | Black Crow AI, Inc. affiliates | Equity | Preferred Stock        
Investment Holdings [Line Items]        
Investment cost [2],[39] $ 3,000      
Total investments at fair value [39] $ 3,000      
Acquisition Date [9] Mar. 24, 2021 Mar. 24, 2021    
Shares | shares [39] 3 3    
Software | Nextroll, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2023-07 2023-07    
Investment Interest Rate Floor [7] 7.75% 7.75%    
Investment Interest Rate Paid in Kind [7] 2.95% 2.95%    
Principal Amount [11],[18] $ 22,211      
Investment cost [2],[11],[18] 22,284      
Total investments at fair value [11],[18] $ 22,284      
Software | Nextroll, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 1.95% 1.95%    
Software | Nextroll, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.75% 3.75%    
Software | 3GTMS, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-02 2025-02 2025-02 2025-02
Investment Interest Rate Floor 10.28% [7] 10.28% [7] 10.28% [12] 10.28% [12]
Principal Amount $ 10,426 [13],[14]   $ 10,000 [3],[16]  
Investment cost 10,291 [2],[13],[14]   9,812 [1],[3],[16]  
Total investments at fair value $ 10,317 [13],[14]   $ 9,656 [3],[16]  
Software | 3GTMS, LLC | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 9.28% [7] 9.28% [7] 9.28% [12] 9.28% [12]
Software | 3GTMS, LLC | Debt Investments        
Investment Holdings [Line Items]        
Principal Amount $ 13,176      
Investment cost [2] 13,035      
Total investments at fair value 12,998      
Software | 3GTMS, LLC | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost 1,000 [2]   $ 1,000 [1]  
Total investments at fair value $ 793   $ 985  
Acquisition Date Aug. 09, 2021 [9] Aug. 09, 2021 [9] Aug. 09, 2021 [6] Aug. 09, 2021 [6]
Shares | shares 1,000,000 1,000,000 1,000,000 1,000,000
Software | 3GTMS One, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-02 2025-02    
Investment Interest Rate Floor [7] 7.57% 7.57%    
Principal Amount [14] $ 2,750      
Investment cost [2],[14] 2,744      
Total investments at fair value [14] $ 2,681      
Software | 3GTMS One, LLC | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 6.57% 6.57%    
Software | Agilence, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-10 2026-10 2026-10 2026-10
Investment Interest Rate Floor 10.00% [7] 10.00% [7] 10.00% [12] 10.00% [12]
Principal Amount $ 9,306 [8],[14],[18]   $ 9,400 [3]  
Investment cost 9,088 [2],[8],[14],[18]   9,138 [1],[3]  
Total investments at fair value $ 8,977 [8],[14],[18]   $ 9,138 [3]  
Software | Agilence, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     9.00% 9.00%
Software | Agilence, Inc. | Senior Secured Debt | BSBY        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 9.00% 9.00%    
Software | Brain Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-04 2025-04 2025-04 2025-04
Investment Interest Rate Floor 6.95% [7] 6.95% [7] 6.95% [12] 6.95% [12]
Investment Interest Rate Paid in Kind 1.00% [7] 1.00% [7] 1.00% [12] 1.00% [12]
Principal Amount $ 20,166 [8],[11],[17],[25]   $ 10,016 [3],[20],[31]  
Investment cost 20,242 [2],[8],[11],[17],[25]   9,943 [1],[3],[20],[31]  
Total investments at fair value $ 20,138 [8],[11],[17],[25]   $ 9,943 [3],[20],[31]  
Software | Brain Corporation | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 3.95% [7] 3.95% [7] 3.95% [12] 3.95% [12]
Software | Brain Corporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 3.70% [7] 3.70% [7] 3.70% [12] 3.70% [12]
Software | Brain Corporation | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 165 [2],[25]   $ 165 [1],[31]  
Total investments at fair value $ 61 [25]   $ 132 [31]  
Acquisition Date Oct. 04, 2021 [9] Oct. 04, 2021 [9] Oct. 04, 2021 [6] Oct. 04, 2021 [6]
Shares | shares 194,629 [25] 194,629 [25] 194,629 [31] 194,629 [31]
Software | Campaign Monitor Limited | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-11 2025-11 2025-11 2025-11
Investment Interest Rate Floor 9.90% [7] 9.90% [7] 11.15% [12] 11.15% [12]
Principal Amount $ 33,000 [10],[17]   $ 33,000 [22]  
Investment cost 32,578 [7],[10],[17]   32,459 [1],[22]  
Total investments at fair value $ 33,000 [10],[17]   $ 33,000 [22]  
Software | Campaign Monitor Limited | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     7.90% 7.90%
Software | Campaign Monitor Limited | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.90% 8.90%    
Software | Ceros, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2026-09 2026-09
Investment Interest Rate Floor [12]     9.89% 9.89%
Principal Amount [3],[16]     $ 17,978  
Investment cost [1],[3],[16]     17,474  
Total investments at fair value [3],[16]     $ 17,474  
Software | Ceros, LLC | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     8.89% 8.89%
Software | Cloud 9 Software | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-04 2024-04
Investment Interest Rate Floor [12]     9.20% 9.20%
Principal Amount [32]     $ 9,953  
Investment cost [1],[32]     9,856  
Total investments at fair value [32]     $ 9,953  
Software | Cloud 9 Software | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     8.20% 8.20%
Software | CloudBolt Software, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-10 2024-10 2024-10 2024-10
Investment Interest Rate Floor 9.95% [7] 9.95% [7] 9.95% [12] 9.95% [12]
Principal Amount $ 10,000 [10],[13]   $ 10,000 [15],[22],[32]  
Investment cost 10,069 [2],[10],[13]   9,923 [1],[15],[22],[32]  
Total investments at fair value $ 10,498 [10],[13]   $ 10,035 [15],[22],[32]  
Software | CloudBolt Software, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 3.45% [7] 3.45% [7] 2.95% [12] 2.95% [12]
Software | CloudBolt Software, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.70% [7] 6.70% [7] 6.70% [12] 6.70% [12]
Software | CloudBolt Software, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 117 [2]   $ 117 [1]  
Total investments at fair value $ 1   $ 85  
Acquisition Date Sep. 30, 2020 [9] Sep. 30, 2020 [9] Sep. 30, 2020 [6] Sep. 30, 2020 [6]
Shares | shares 211,342 211,342 211,342 211,342
Software | Cybermaxx Intermediate Holdings, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-08 2026-08 2026-08 2026-08
Investment Interest Rate Floor 10.28% [7] 10.28% [7] 10.28% [12] 10.28% [12]
Principal Amount $ 10,528 [8],[17]   $ 8,000 [3]  
Investment cost 10,298 [2],[8],[17]   7,801 [1],[3]  
Total investments at fair value $ 10,114 [8],[17]   $ 7,801 [3]  
Software | Cybermaxx Intermediate Holdings, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     9.28% 9.28%
Software | Cybermaxx Intermediate Holdings, Inc. | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 9.53% 9.53%    
Software | Dashlane, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-07 2025-07 2025-07 2025-07
Investment Interest Rate Floor 7.55% [7] 7.55% [7] 7.55% [12] 7.55% [12]
Investment Interest Rate Paid in Kind 1.10% [7] 1.10% [7] 1.10% [12] 1.10% [12]
Principal Amount $ 31,930 [8],[10],[11],[13],[17]   $ 20,719 [3],[15],[20],[22]  
Investment cost 32,346 [2],[8],[10],[11],[13],[17]   21,807 [1],[3],[15],[20],[22]  
Total investments at fair value $ 32,012 [8],[10],[11],[13],[17]   $ 21,734 [3],[15],[20],[22]  
Software | Dashlane, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 4.95% [7] 4.95% [7] 7.10% [12] 7.10% [12]
Software | Dashlane, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 3.05% [7] 3.05% [7] 3.05% [12] 3.05% [12]
Software | Dashlane, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 353 [2]   $ 404 [1]  
Total investments at fair value $ 168   $ 415  
Acquisition Date Mar. 11, 2019 [9] Mar. 11, 2019 [9] Mar. 11, 2019 [6] Mar. 11, 2019 [6]
Shares | shares 453,641 453,641 560,536 560,536
Software | Delphix Corp. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2023-02 2023-02
Investment Interest Rate Floor [12]     10.25% 10.25%
Principal Amount [21],[22],[32]     $ 60,000  
Investment cost [1],[21],[22],[32]     61,736  
Total investments at fair value [21],[22],[32]     $ 62,345  
Software | Delphix Corp. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     5.00% 5.00%
Software | Delphix Corp. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.50% 5.50%
Software | Delphix Corp. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 1,594 [2]   $ 1,594 [1],[21]  
Total investments at fair value $ 2,657   $ 3,275 [21]  
Acquisition Date Oct. 08, 2019 [9] Oct. 08, 2019 [9] Oct. 08, 2019 [6] Oct. 08, 2019 [6]
Shares | shares 718,898 718,898 718,898 [21] 718,898 [21]
Software | Demandbase, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-08 2025-08 2025-08 2025-08
Investment Interest Rate Floor 5.50% [7] 5.50% [7] 8.50% [12] 8.50% [12]
Investment Interest Rate Paid in Kind [7] 3.00% 3.00%    
Principal Amount $ 28,503 [8],[10],[11],[17]   $ 16,875 [3],[22]  
Investment cost 28,442 [2],[8],[10],[11],[17]   16,463 [1],[3],[22]  
Total investments at fair value $ 28,664 [8],[10],[11],[17]   $ 16,463 [3],[22]  
Software | Demandbase, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Investment Interest Rate Floor [12]     2.00% 2.00%
Interest Rate and Floor [7] 5.00% 5.00%    
Software | Demandbase, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 2.25% [7] 2.25% [7] 5.25% [12] 5.25% [12]
Software | Demandbase, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 545 [2]   $ 404 [1]  
Total investments at fair value $ 180   $ 443  
Acquisition Date Aug. 02, 2021 [9] Aug. 02, 2021 [9] Aug. 02, 2021 [6] Aug. 02, 2021 [6]
Shares | shares 727,047 727,047 483,248 483,248
Software | Enmark Systems, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-09 2026-09 2026-09 2026-09
Investment Interest Rate Floor 7.77% [7] 7.77% [7] 7.83% [12] 7.83% [12]
Investment Interest Rate Paid in Kind 2.16% [7] 2.16% [7] 2.19% [12] 2.19% [12]
Principal Amount $ 8,223 [8],[11],[13],[14]   $ 8,000 [3],[15],[16]  
Investment cost 8,054 [2],[8],[11],[13],[14]   7,798 [1],[3],[15],[16]  
Total investments at fair value $ 8,043 [8],[11],[13],[14]   $ 7,798 [3],[15],[16]  
Software | Enmark Systems, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 6.77% [7] 6.77% [7] 6.83% [12] 6.83% [12]
Software | Esentire, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-05 2024-05 2024-05 2024-05
Investment Interest Rate Floor 10.96% [7] 10.96% [7] 10.96% [12] 10.96% [12]
Principal Amount $ 8,436 [13],[14],[23],[24]   $ 21,000 [4],[5],[15],[16]  
Investment cost 8,361 [2],[13],[14],[23],[24]   20,699 [1],[4],[5],[15],[16]  
Total investments at fair value $ 8,376 [13],[14],[23],[24]   $ 20,750 [4],[5],[15],[16]  
Software | Esentire, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 9.96% [7] 9.96% [7] 9.96% [12] 9.96% [12]
Software | Gryphon Networks Corp. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2026-01 2026-01
Investment Interest Rate Floor [12]     10.69% 10.69%
Principal Amount [3],[15]     $ 5,232  
Investment cost [1],[3],[15]     5,106  
Total investments at fair value [3],[15]     $ 5,088  
Software | Gryphon Networks Corp. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     9.69% 9.69%
Software | Ikon Science Limited | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-10 2024-10 2024-10 2024-10
Investment Basis Spread Variable Rate [7] 9.00% 9.00%    
Investment Interest Rate Floor 10.00% [7] 10.00% [7] 10.00% [12] 10.00% [12]
Principal Amount $ 6,563 [8],[14],[23],[24]   $ 6,913 [3],[4],[5],[16]  
Investment cost 6,422 [2],[8],[14],[23],[24]   6,719 [1],[3],[4],[5],[16]  
Total investments at fair value $ 6,484 [8],[14],[23],[24]   $ 6,767 [3],[4],[5],[16]  
Software | Ikon Science Limited | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     9.00% 9.00%
Software | Imperva, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-01 2027-01 2027-01 2027-01
Investment Interest Rate Floor 8.75% [7] 8.75% [7] 8.75% [12] 8.75% [12]
Principal Amount $ 20,000 [10]   $ 20,000 [22]  
Investment cost 19,875 [2],[10]   19,851 [1],[22]  
Total investments at fair value $ 20,200 [10]   $ 20,000 [22]  
Software | Imperva, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 7.75% [7] 7.75% [7] 7.75% [12] 7.75% [12]
Software | Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2023-07 2023-07 2023-07 2023-07
Investment Interest Rate Floor 11.14% [7] 11.14% [7] 11.14% [12] 11.14% [12]
Principal Amount $ 10,681 [14]   $ 8,571 [16]  
Investment cost 10,593 [2],[14]   8,403 [1],[16]  
Total investments at fair value $ 10,593 [14]   $ 8,375 [16]  
Software | Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     10.14% 10.14%
Software | Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.) | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 10.14% 10.14%    
Software | Khoros (p.k.a Lithium Technologies) | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-01 2024-01 2022-10 2022-10
Investment Interest Rate Floor 9.00% [7] 9.00% [7] 9.00% [12] 9.00% [12]
Principal Amount $ 56,208 [8]   $ 56,208 [3]  
Investment cost 56,062 [2],[8]   55,834 [1],[3]  
Total investments at fair value $ 55,520 [8]   $ 55,834 [3]  
Software | Khoros (p.k.a Lithium Technologies) | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     8.00% 8.00%
Software | Khoros (p.k.a Lithium Technologies) | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.00% 8.00%    
Software | Logicworks | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-01 2024-01 2024-01 2024-01
Investment Interest Rate Floor 10.75% [7] 10.75% [7] 10.75% [12] 10.75% [12]
Principal Amount $ 14,500 [18]   $ 10,000 [3],[32]  
Investment cost 14,398 [2],[18]   9,862 [1],[3],[32]  
Total investments at fair value $ 14,473 [18]   $ 9,965 [3],[32]  
Software | Logicworks | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 7.50% [7] 7.50% [7] 7.50% [12] 7.50% [12]
Software | Mixpanel, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-08 2024-08
Investment Interest Rate Floor [12]     7.95% 7.95%
Investment Interest Rate Paid in Kind [12]     1.80% 1.80%
Principal Amount [20],[22],[32]     $ 20,431  
Investment cost [1],[20],[22],[32]     20,292  
Total investments at fair value [20],[22],[32]     $ 21,030  
Software | Mixpanel, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     3.00% 3.00%
Software | Mixpanel, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     4.70% 4.70%
Software | Mixpanel, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 252 [2]   $ 252 [1]  
Total investments at fair value $ 225   $ 906  
Acquisition Date Sep. 30, 2020 [9] Sep. 30, 2020 [9] Sep. 30, 2020 [6] Sep. 30, 2020 [6]
Shares | shares 82,362 82,362 82,362 82,362
Software | Mobile Solutions Services | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-12 2025-12 2025-12 2025-12
Investment Interest Rate Floor 10.06% [7] 10.06% [7] 10.87% [12] 10.87% [12]
Principal Amount $ 17,915 [8],[14]   $ 19,074 [3],[16]  
Investment cost 17,556 [2],[8],[14]   18,575 [1],[3],[16]  
Total investments at fair value $ 17,474 [8],[14]   $ 18,834 [3],[16]  
Software | Mobile Solutions Services | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 9.06% [7] 9.06% [7] 9.87% [12] 9.87% [12]
Software | Nuvolo Technologies Corporation | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-07 2025-07 2025-07 2025-07
Investment Interest Rate Floor 8.50% [7] 8.50% [7] 10.95% [12] 10.95% [12]
Principal Amount $ 22,500 [8],[10],[17],[18]   $ 15,000 [22],[32]  
Investment cost 22,508 [2],[8],[10],[17],[18]   14,967 [1],[22],[32]  
Total investments at fair value $ 22,817 [8],[10],[17],[18]   $ 15,017 [22],[32]  
Software | Nuvolo Technologies Corporation | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 2.42% [7] 2.42% [7] 1.75% [12] 1.75% [12]
Software | Nuvolo Technologies Corporation | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 5.25% [7] 5.25% [7] 7.70% [12] 7.70% [12]
Software | Nuvolo Technologies Corporation | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 172 [2],[18]   $ 88 [1]  
Total investments at fair value $ 175 [18]   $ 283  
Acquisition Date Mar. 29, 2019 [9] Mar. 29, 2019 [9] Mar. 29, 2019 [6] Mar. 29, 2019 [6]
Shares | shares 70,000 [18] 70,000 [18] 50,000 50,000
Software | Pollen, Inc. One | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2023-11 2023-11
Investment Interest Rate Floor [12]     8.00% 8.00%
Investment Interest Rate Paid in Kind [12]     0.50% 0.50%
Principal Amount [20]     $ 7,457  
Investment cost [1],[20]     7,528  
Total investments at fair value [20]     $ 7,314  
Software | Pollen, Inc. One | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     4.50% 4.50%
Software | Pollen, Inc. One | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     4.75% 4.75%
Software | Pollen, Inc. Two | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2023-11 2023-11
Investment Interest Rate Floor [12],[20]     8.50% 8.50%
Investment Interest Rate Paid in Kind [12]     1.35% 1.35%
Principal Amount [20],[31]     $ 13,041  
Investment cost [1],[20],[31]     13,005  
Total investments at fair value [20],[31]     $ 13,092  
Software | Pollen, Inc. Two | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     4.50% 4.50%
Software | Pollen, Inc. Two | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.25% 5.25%
Software | Pollen, Inc. | Debt Investments        
Investment Holdings [Line Items]        
Principal Amount $ 20,498      
Investment cost [1] 20,533      
Total investments at fair value 20,406      
Software | Pymetrics, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2022-10 2022-10
Investment Interest Rate Floor [12]     8.75% 8.75%
Investment Interest Rate Paid in Kind [12]     1.75% 1.75%
Principal Amount [20]     $ 9,667  
Investment cost [1],[20]     9,845  
Total investments at fair value [20]     $ 9,845  
Software | Pymetrics, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     4.00% 4.00%
Software | Pymetrics, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.50% 5.50%
Software | Pymetrics, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 77  
Total investments at fair value     $ 218  
Acquisition Date [6]     Sep. 15, 2020 Sep. 15, 2020
Shares | shares     150,943 150,943
Software | Regent Education | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2022-01 2022-01
Investment Interest Rate Paid in Kind [12]     2.00% 2.00%
Principal Amount [20],[37]     $ 2,951  
Investment Interest Rate Paid in Cash [12]     10.00% 10.00%
Investment cost [1],[20],[37]     $ 3,064  
Total investments at fair value [20],[37]     $ 2,608  
Software | Regent Education | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     7.94% 7.94%
Software | Reltio Inc | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2023-07 2023-07
Investment Interest Rate Floor [12]     8.95% 8.95%
Investment Interest Rate Paid in Kind [12]     1.70% 1.70%
Principal Amount [20],[22]     $ 10,248  
Investment cost [1],[20],[22]     10,336  
Total investments at fair value [20],[22]     $ 10,542  
Software | Reltio Inc | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     4.95% 4.95%
Software | Reltio Inc | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     5.70% 5.70%
Software | Reltio Inc | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost 215 [2]   $ 215 [1]  
Total investments at fair value $ 298   $ 637  
Acquisition Date Jun. 30, 2020 [9] Jun. 30, 2020 [9] Jun. 30, 2020 [6] Jun. 30, 2020 [6]
Shares | shares 69,120 69,120 69,120 69,120
Software | ShadowDragon, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-12 2026-12 2026-12 2026-12
Investment Interest Rate Floor 10.00% [7] 10.00% [7] 10.00% [12] 10.00% [12]
Principal Amount $ 5,985 [8],[14]   $ 6,000 [3],[16]  
Investment cost 5,841 [2],[8],[14]   5,828 [1],[3],[16]  
Total investments at fair value $ 5,830 [8],[14]   $ 5,828 [3],[16]  
Software | ShadowDragon, LLC | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 9.00% [7] 9.00% [7] 9.00% [12] 9.00% [12]
Software | Tact.ai Technologies, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-02 2024-02 2024-02 2024-02
Investment Interest Rate Floor 8.75% [7] 8.75% [7] 8.75% [12] 8.75% [12]
Investment Interest Rate Paid in Kind 2.00% [7] 2.00% [7] 2.00% [12] 2.00% [12]
Principal Amount $ 4,250 [11]   $ 5,185 [20]  
Investment cost 4,481 [2],[11]   5,305 [1],[20]  
Total investments at fair value $ 4,446 [11]   $ 5,245 [20]  
Software | Tact.ai Technologies, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor 5.50% [7] 5.50% [7] 5.50% [12] 5.50% [12]
Software | Tact.ai Technologies, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 4.00% [7] 4.00% [7] 4.00% [12] 4.00% [12]
Software | Tact.ai Technologies, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 206 [2]   $ 206 [1]  
Total investments at fair value $ 69   $ 162  
Acquisition Date Feb. 13, 2020 [9] Feb. 13, 2020 [9] Feb. 13, 2020 [6] Feb. 13, 2020 [6]
Shares | shares 1,041,667 1,041,667 1,041,667 1,041,667
Software | Copper CRM, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-03 2025-03    
Investment Interest Rate Floor [7] 8.25% 8.25%    
Investment Interest Rate Paid in Kind [7] 1.95% 1.95%    
Principal Amount [11],[13] $ 10,144      
Investment cost [2],[11],[13] 10,150      
Total investments at fair value [11],[13] $ 9,820      
Software | Copper CRM, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 4.50% 4.50%    
Software | Copper CRM, Inc. | Senior Secured Debt | Cap rate        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 10.25% 10.25%    
Software | Copper CRM, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.50% 4.50%    
Software | ThreatConnect, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-05 2026-05 2026-05 2026-05
Investment Interest Rate Floor 10.00% [7] 10.00% [7] 10.00% [12] 10.00% [12]
Principal Amount $ 11,032 [8],[14]   $ 11,144 [3],[16],[32]  
Investment cost 10,778 [2],[8],[14]   10,831 [1],[3],[16],[32]  
Total investments at fair value $ 10,793 [8],[14]   $ 10,859 [3],[16],[32]  
Software | ThreatConnect, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate 9.00% [7] 9.00% [7] 9.00% [12] 9.00% [12]
Software | Udacity, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2024-09 2024-09
Investment Interest Rate Floor [12]     7.75% 7.75%
Investment Interest Rate Paid in Kind [12]     2.00% 2.00%
Principal Amount [20],[32]     $ 50,895  
Investment cost [1],[20],[32]     50,646  
Total investments at fair value [20],[32]     $ 51,722  
Software | Udacity, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     3.00% 3.00%
Software | Udacity, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     4.50% 4.50%
Software | Udacity, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 218  
Total investments at fair value     $ 345  
Acquisition Date [6]     Sep. 25, 2020 Sep. 25, 2020
Shares | shares     486,359 486,359
Software | Zimperium, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-05 2027-05 2024-07 2024-07
Investment Interest Rate Floor 9.31% [7] 9.31% [7] 9.95% [12] 9.95% [12]
Principal Amount $ 16,313 [8],[14]   $ 15,633 [16],[32]  
Investment cost 16,000 [2],[8],[14]   15,347 [1],[16],[32]  
Total investments at fair value $ 16,072 [8],[14]   $ 15,347 [16],[32]  
Software | Zimperium, Inc. | Senior Secured Debt | LIBOR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     8.95% 8.95%
Software | Zimperium, Inc. | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.31% 8.31%    
Software | Zimperium, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [1]     $ 72  
Total investments at fair value     $ 56  
Acquisition Date [6]     Jul. 02, 2021 Jul. 02, 2021
Shares | shares     20,563 20,563
Software | Cap Linked Inc [Member] | Equity | Preferred Series A-3        
Investment Holdings [Line Items]        
Investment cost $ 51 [2]   $ 51 [1]  
Total investments at fair value $ 6   $ 65  
Acquisition Date Oct. 26, 2012 [9] Oct. 26, 2012 [9] Oct. 26, 2012 [6] Oct. 26, 2012 [6]
Shares | shares 53,614 53,614 53,614 53,614
Software | Docker Inc [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 4,284 [2]   $ 4,284 [1]  
Total investments at fair value $ 503   $ 3  
Acquisition Date Nov. 29, 2018 [9] Nov. 29, 2018 [9] Nov. 29, 2018 [6] Nov. 29, 2018 [6]
Shares | shares 20,000 20,000 20,000 20,000
Software | Druva Holdings Inc [Member] | Equity        
Investment Holdings [Line Items]        
Investment cost $ 1,300 [2]   $ 1,300 [1]  
Total investments at fair value $ 2,159   $ 2,916  
Shares | shares 552,461 552,461 552,461 552,461
Software | Druva Holdings Inc [Member] | Equity | Preferred Series 3        
Investment Holdings [Line Items]        
Investment cost [2] $ 300      
Total investments at fair value $ 395      
Acquisition Date [9] Aug. 24, 2017 Aug. 24, 2017    
Shares | shares 93,620 93,620    
Software | Druva Holdings Inc [Member] | Equity | Preferred Series 2        
Investment Holdings [Line Items]        
Investment cost $ 1,000 [2]   $ 1,000 [1]  
Total investments at fair value $ 1,764   $ 2,387  
Acquisition Date Oct. 22, 2015 [9] Oct. 22, 2015 [9] Oct. 22, 2015 [6] Oct. 22, 2015 [6]
Shares | shares 458,841 458,841 458,841 458,841
Software | Druva Holdings Inc One [Member] | Equity | Preferred Series 3        
Investment Holdings [Line Items]        
Investment cost [1]     $ 300  
Total investments at fair value     $ 529  
Acquisition Date [6]     Aug. 24, 2017 Aug. 24, 2017
Shares | shares     93,620 93,620
Software | High Roads Inc [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 307 [2]   $ 307 [1]  
Total investments at fair value      
Acquisition Date Jan. 18, 2013 [9] Jan. 18, 2013 [9] Jan. 18, 2013 [6] Jan. 18, 2013 [6]
Shares | shares 190 190 190 190
Software | Lightbend Inc [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 265 [2]   $ 265 [1]  
Total investments at fair value $ 24   $ 5  
Acquisition Date Dec. 04, 2020 [9] Dec. 04, 2020 [9] Dec. 04, 2020 [6] Dec. 04, 2020 [6]
Shares | shares 38,461 38,461 38,461 38,461
Software | Lightbend Inc [Member] | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost $ 131 [2]   $ 131 [1]  
Total investments at fair value $ 1   $ 0  
Acquisition Date Feb. 14, 2018 [9] Feb. 14, 2018 [9] Feb. 14, 2018 [6] Feb. 14, 2018 [6]
Shares | shares 89,685 89,685 89,685 89,685
Software | Palantir Technologies [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 8,670 [2],[9]   $ 8,670 [1],[6]  
Total investments at fair value $ 9,106 [9]   $ 25,828 [6]  
Acquisition Date Sep. 23, 2020 [9] Sep. 23, 2020 [9] Sep. 23, 2020 [6] Sep. 23, 2020 [6]
Shares | shares 1,418,337 [9] 1,418,337 [9] 1,418,337 [6] 1,418,337 [6]
Software | Single Store Inc [Member] | Equity        
Investment Holdings [Line Items]        
Investment cost $ 2,280 [2]   $ 2,279 [1]  
Total investments at fair value $ 2,161   $ 2,479  
Shares | shares 633,939 633,939 633,939 633,939
Software | Single Store Inc [Member] | Equity | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost $ 2,000 [2]   $ 2,000 [1]  
Total investments at fair value $ 1,940   $ 2,239  
Acquisition Date Nov. 25, 2020 [9] Nov. 25, 2020 [9] Nov. 25, 2020 [6] Nov. 25, 2020 [6]
Shares | shares 580,983 580,983 580,983 580,983
Software | Single Store Inc [Member] | Equity | Preferred Series F        
Investment Holdings [Line Items]        
Investment cost [2] $ 280      
Total investments at fair value $ 221      
Acquisition Date [9] Aug. 12, 2021 Aug. 12, 2021    
Shares | shares 52,956 52,956    
Software | Single Store Inc [Member] | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost $ 103 [2]   $ 103 [1]  
Total investments at fair value $ 426   $ 704  
Acquisition Date Apr. 28, 2020 [9] Apr. 28, 2020 [9] Apr. 28, 2020 [6] Apr. 28, 2020 [6]
Shares | shares 312,596 312,596 312,596 312,596
Software | Single Store Inc One [Member] | Equity | Preferred Series F        
Investment Holdings [Line Items]        
Investment cost [1]     $ 279  
Total investments at fair value     $ 240  
Acquisition Date [6]     Aug. 12, 2021 Aug. 12, 2021
Shares | shares     52,956 52,956
Software | Sprinklr Inc [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 3,748 [2],[9]   $ 3,749 [1],[6]  
Total investments at fair value $ 5,719 [9]   $ 11,109 [6]  
Acquisition Date Mar. 22, 2017 [9] Mar. 22, 2017 [9] Mar. 22, 2017 [6] Mar. 22, 2017 [6]
Shares | shares 700,000 [9] 700,000 [9] 700,000 [6] 700,000 [6]
Software | Verana Health Inc [Member] | Equity | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost $ 2,000 [2]   $ 2,000 [1]  
Total investments at fair value $ 1,023   $ 1,697  
Acquisition Date Jul. 08, 2021 [9] Jul. 08, 2021 [9] Jul. 08, 2021 [6] Jul. 08, 2021 [6]
Shares | shares 952,562 952,562 952,562 952,562
Software | Dispatch Technologies, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2028-04 2028-04    
Investment Interest Rate Floor [7] 8.76% 8.76%    
Principal Amount [8],[14] $ 7,500      
Investment cost [2],[8],[14] 7,295      
Total investments at fair value [8],[14] $ 7,339      
Software | Dispatch Technologies, Inc. | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.01% 8.01%    
Software | Eigen Technologies Ltd. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-04 2025-04    
Investment Interest Rate Floor [7] 8.35% 8.35%    
Principal Amount [23],[24] $ 3,750      
Investment cost [2],[23],[24] 3,744      
Total investments at fair value [23],[24] $ 3,746      
Software | Eigen Technologies Ltd. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 2.95% 2.95%    
Software | Eigen Technologies Ltd. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.10% 5.10%    
Software | Eigen Technologies Ltd. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[23],[24] $ 8      
Total investments at fair value [23],[24] $ 6      
Acquisition Date [9] Apr. 13, 2022 Apr. 13, 2022    
Shares | shares [23],[24] 522 522    
Software | Elation Health, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2026-03 2026-03    
Investment Interest Rate Floor [7] 9.00% 9.00%    
Investment Interest Rate Paid in Kind [7] 1.95% 1.95%    
Principal Amount [8],[10],[11] $ 5,021      
Investment cost [2],[8],[10],[11] 4,839      
Total investments at fair value [8],[10],[11] $ 4,839      
Software | Elation Health, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.95% 3.95%    
Software | Elation Health, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.25% 4.25%    
Software | Elation Health, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 583      
Total investments at fair value $ 382      
Acquisition Date [9] Sep. 12, 2022 Sep. 12, 2022    
Shares | shares 362,837 362,837    
Software | Esme Learning Solutions, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-02 2025-02    
Investment Interest Rate Floor [7] 8.75% 8.75%    
Investment Interest Rate Paid in Kind [7] 1.50% 1.50%    
Principal Amount [11],[28] $ 4,892      
Investment cost [2],[11],[28] 4,737      
Total investments at fair value [11],[28] $ 1,671      
Software | Esme Learning Solutions, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.00% 3.00%    
Software | Esme Learning Solutions, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 5.50% 5.50%    
Software | Esme Learning Solutions, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 198      
Total investments at fair value      
Acquisition Date [9] Jan. 27, 2022 Jan. 27, 2022    
Shares | shares 56,765 56,765    
Software | Fortified Health Security | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-12 2027-12    
Investment Interest Rate Floor [7] 8.54% 8.54%    
Principal Amount [8],[14] $ 7,000      
Investment cost [2],[8],[14] 6,824      
Total investments at fair value [8],[14] $ 6,824      
Software | Fortified Health Security | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 7.79% 7.79%    
Software | Flight Schedule Pro, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-10 2027-10    
Investment Interest Rate Floor [7] 8.70% 8.70%    
Principal Amount [8],[14] $ 5,948      
Investment cost [2],[8],[14] 5,771      
Total investments at fair value [8],[14] $ 5,771      
Software | Flight Schedule Pro, LLC | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 7.79% 7.79%    
Software | Salary.com, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-09 2027-09    
Investment Interest Rate Floor [7] 9.00% 9.00%    
Principal Amount [14] $ 18,000      
Investment cost [2],[14] 17,654      
Total investments at fair value [14] $ 17,654      
Software | Salary.com, LLC | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.00% 8.00%    
Software | Riviera Partners LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-04 2027-04    
Investment Interest Rate Floor [7] 8.53% 8.53%    
Principal Amount [8],[14] $ 26,184      
Investment cost [2],[8],[14] 25,622      
Total investments at fair value [8],[14] $ 25,487      
Software | Riviera Partners LLC | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 7.53% 7.53%    
Software | Omeda Holdings, LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-07 2027-07    
Investment Interest Rate Floor [7] 9.05% 9.05%    
Principal Amount [8],[14] $ 7,500      
Investment cost [2],[8],[14] 7,261      
Total investments at fair value [8],[14] $ 7,261      
Software | Omeda Holdings, LLC | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.05% 8.05%    
Software | VideoAmp, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-02 2025-02    
Investment Interest Rate Floor [7] 6.95% 6.95%    
Investment Interest Rate Paid in Kind [7] 1.25% 1.25%    
Principal Amount [10],[11],[25] $ 63,187      
Investment cost [2],[10],[11],[25] 62,640      
Total investments at fair value [10],[11],[25] $ 63,429      
Software | VideoAmp, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 5.25% 5.25%    
Software | VideoAmp, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 3.70% 3.70%    
Software | VideoAmp, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[25] $ 1,275      
Total investments at fair value [25] $ 321      
Acquisition Date [9] Jan. 21, 2022 Jan. 21, 2022    
Shares | shares [25] 152,048 152,048    
Software | Zappi, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2027-12 2027-12    
Investment Interest Rate Floor [7] 9.03% 9.03%    
Principal Amount [8],[14],[23],[24] $ 9,000      
Investment cost [2],[8],[14],[23],[24] 8,779      
Total investments at fair value [8],[14],[23],[24] $ 8,779      
Software | Zappi, Inc. | Senior Secured Debt | SOFR        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 8.03% 8.03%    
Surgical Devices        
Investment Holdings [Line Items]        
Total investments at fair value $ 3,038   $ 1,029  
Surgical Devices | Equity        
Investment Holdings [Line Items]        
Investment cost 2,479 [2]   1,941  
Total investments at fair value 2,546   543  
Surgical Devices | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 46 [2]   206 [1]  
Total investments at fair value 492   486  
Surgical Devices | TransMedics Group, Inc. (p.k.a Transmedics, Inc.) | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] 538      
Total investments at fair value [9] $ 2,546      
Acquisition Date [9] Nov. 07, 2012 Nov. 07, 2012    
Shares | shares [9] 50,000 50,000    
Surgical Devices | TransMedics Group, Inc. (p.k.a Transmedics, Inc.) | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 39 [2],[9]   139 [1],[6]  
Total investments at fair value $ 492 [9]   $ 480 [6]  
Acquisition Date Sep. 11, 2015 [9] Sep. 11, 2015 [9] Nov. 07, 2012 [6] Nov. 07, 2012 [6]
Shares | shares 14,440 [9] 14,440 [9] 64,440 [6] 64,440 [6]
Surgical Devices | Gynesonics, Inc. | Equity        
Investment Holdings [Line Items]        
Investment cost $ 1,941 [2]   $ 1,941  
Total investments at fair value   $ 543  
Shares | shares 9,595,178 9,595,178 9,595,178 9,595,178
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost $ 712 [2]   $ 712 [1]  
Total investments at fair value   $ 81  
Acquisition Date Feb. 08, 2013 [9] Feb. 08, 2013 [9] Feb. 08, 2013 [6] Feb. 08, 2013 [6]
Shares | shares 1,991,157 1,991,157 1,991,157 1,991,157
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost $ 250 [2]   $ 250 [1]  
Total investments at fair value   $ 9  
Acquisition Date Jan. 18, 2007 [9] Jan. 18, 2007 [9] Jan. 18, 2007 [6] Jan. 18, 2007 [6]
Shares | shares 219,298 219,298 219,298 219,298
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost $ 282 [2]   $ 282 [1]  
Total investments at fair value   $ 26  
Acquisition Date Jun. 16, 2010 [9] Jun. 16, 2010 [9] Jun. 16, 2010 [6] Jun. 16, 2010 [6]
Shares | shares 656,538 656,538 656,538 656,538
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost $ 429 [2]   $ 429 [1]  
Total investments at fair value   $ 131  
Acquisition Date Jul. 14, 2015 [9] Jul. 14, 2015 [9] Jul. 14, 2015 [6] Jul. 14, 2015 [6]
Shares | shares 2,786,367 2,786,367 2,786,367 2,786,367
Surgical Devices | Gynesonics, Inc. | Equity | Preferred Series F        
Investment Holdings [Line Items]        
Investment cost $ 118 [2]   $ 118 [1]  
Total investments at fair value   $ 123  
Acquisition Date Dec. 18, 2018 [9] Dec. 18, 2018 [9] Dec. 18, 2018 [6] Dec. 18, 2018 [6]
Shares | shares 1,523,693 1,523,693 1,523,693 1,523,693
Surgical Devices | Gynesonics, Inc. | Equity | Series F One Preferred Stock        
Investment Holdings [Line Items]        
Investment cost $ 150 [2]   $ 150 [1]  
Total investments at fair value   $ 173  
Acquisition Date Dec. 18, 2018 [9] Dec. 18, 2018 [9] Dec. 18, 2018 [6] Dec. 18, 2018 [6]
Shares | shares 2,418,125 2,418,125 2,418,125 2,418,125
Surgical Devices | Gynesonics, Inc. | Warrant Investment | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost $ 7 [2]   $ 67 [1]  
Total investments at fair value   $ 6  
Acquisition Date Jan. 16, 2013 [9] Jan. 16, 2013 [9] Feb. 08, 2012 [6] Feb. 08, 2012 [6]
Shares | shares 16,835 16,835 151,123 151,123
Surgical Devices | High Roads Inc [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Total investments at fair value     $ 0  
Medical Devices & Equipment        
Investment Holdings [Line Items]        
Total investments at fair value $ 1,834   12,612  
Medical Devices & Equipment | Equity        
Investment Holdings [Line Items]        
Investment cost [2] 2,953      
Total investments at fair value 915   10,538  
Medical Devices & Equipment | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 2,034 [2]   2,483 [1]  
Total investments at fair value 919   2,074  
Medical Devices & Equipment | Lucira Health, Inc. [Member] | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9] 110      
Total investments at fair value [9] $ 0      
Acquisition Date [9] Feb. 04, 2022 Feb. 04, 2022    
Shares | shares [9] 59,642 59,642    
Medical Devices & Equipment | Outset Medical, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 401 [2],[9]   401 [1],[6]  
Total investments at fair value $ 864 [9]   $ 1,797 [6]  
Acquisition Date Sep. 27, 2013 [9] Sep. 27, 2013 [9] Sep. 27, 2013 [6] Sep. 27, 2013 [6]
Shares | shares 62,794 [9] 62,794 [9] 62,794 [6] 62,794 [6]
Medical Devices & Equipment | SonaCare Medical, LLC | Warrant Investment | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost [1]     $ 188  
Total investments at fair value     $ 0  
Acquisition Date [6]     Sep. 28, 2012 Sep. 28, 2012
Shares | shares     6,464 6,464
Medical Devices & Equipment | Tela Bio, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 61 [2],[9]   $ 61 [1],[6]  
Total investments at fair value $ 1 [9]   $ 13 [6]  
Acquisition Date Mar. 31, 2017 [9] Mar. 31, 2017 [9] Mar. 31, 2017 [6] Mar. 31, 2017 [6]
Shares | shares 15,712 [9] 15,712 [9] 15,712 [6] 15,712 [6]
Medical Devices & Equipment | Intuity Medical, Inc. | Warrant Investment | Preferred Series B-1        
Investment Holdings [Line Items]        
Investment cost $ 294 [2]   $ 294 [1]  
Total investments at fair value $ 54   $ 264  
Acquisition Date Dec. 29, 2017 [9] Dec. 29, 2017 [9] Dec. 29, 2017 [6] Dec. 29, 2017 [6]
Shares | shares 3,076,323 3,076,323 3,076,323 3,076,323
Medical Devices & Equipment | Aspire Bariatrics, Inc. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 455 [2]   $ 455 [1]  
Total investments at fair value   $ 0  
Acquisition Date Jan. 28, 2015 [9] Jan. 28, 2015 [9] Jan. 28, 2015 [6] Jan. 28, 2015 [6]
Shares | shares 22,572 22,572 22,572 22,572
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity        
Investment Holdings [Line Items]        
Investment cost $ 250 [2]   $ 250 [1]  
Total investments at fair value $ 319   $ 565  
Shares | shares 5,180,000 5,180,000 5,180,000 5,180,000
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity | Preferred Series A-2        
Investment Holdings [Line Items]        
Investment cost [2],[27] $ 250      
Total investments at fair value [27] $ 313      
Acquisition Date [9] Oct. 15, 2021 Oct. 15, 2021    
Shares | shares [27] 5,000,000 5,000,000    
Medical Devices & Equipment | Coronado Aesthetics, LLC | Equity | Common Units        
Investment Holdings [Line Items]        
Investment cost $ 0 [2],[27]   $ 0 [1],[29]  
Total investments at fair value $ 6 [27]   $ 65 [29]  
Acquisition Date Oct. 15, 2021 [9] Oct. 15, 2021 [9] Oct. 15, 2021 [6] Oct. 15, 2021 [6]
Shares | shares 180,000 [27] 180,000 [27] 180,000 [29] 180,000 [29]
Medical Devices & Equipment | Coronado Aesthetics, LLC One | Equity | Preferred Series A-2        
Investment Holdings [Line Items]        
Investment cost [1],[29]     $ 250  
Total investments at fair value [29]     $ 500  
Acquisition Date [6]     Oct. 15, 2021 Oct. 15, 2021
Shares | shares [29]     5,000,000 5,000,000
Medical Devices & Equipment | Phathom Pharmaceuticals, Inc. | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [1]     $ 714  
Medical Devices & Equipment | Flowonix Medical Incorporated [Member] | Equity | Preferred Series AA        
Investment Holdings [Line Items]        
Investment cost $ 1,499 [2]   1,500 [1]  
Total investments at fair value   $ 0  
Acquisition Date Nov. 03, 2014 [9] Nov. 03, 2014 [9] Nov. 03, 2014 [6] Nov. 03, 2014 [6]
Shares | shares 221,893 221,893 221,893 221,893
Medical Devices & Equipment | Flowonix Medical Incorporated [Member] | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost [2] $ 713      
Total investments at fair value   $ 0  
Shares | shares 836,752 836,752 881,131 881,131
Medical Devices & Equipment | Flowonix Medical Incorporated [Member] | Warrant Investment | Preferred Series BB        
Investment Holdings [Line Items]        
Investment cost $ 351 [2]   $ 351 [1]  
Total investments at fair value   $ 0  
Acquisition Date Sep. 21, 2018 [9] Sep. 21, 2018 [9] Sep. 21, 2018 [6] Sep. 21, 2018 [6]
Shares | shares 725,806 725,806 725,806 725,806
Medical Devices & Equipment | Flowonix Medical Incorporated [Member] | Warrant Investment | Preferred Series AA        
Investment Holdings [Line Items]        
Investment cost $ 362 [2]   $ 363 [1],[32]  
Total investments at fair value   $ 0 [32]  
Acquisition Date Nov. 03, 2014 [9] Nov. 03, 2014 [9] Nov. 03, 2014 [6] Nov. 03, 2014 [6]
Shares | shares 110,946 110,946 155,325 [32] 155,325 [32]
Medical Devices & Equipment | Gelesis Inc [Member] | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     $ 1,003  
Total investments at fair value     $ 9,772  
Shares | shares     662,071 662,071
Medical Devices & Equipment | Gelesis Inc [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 871 [2],[9]   $ 0 [1]  
Total investments at fair value $ 433 [9]   $ 3,351  
Acquisition Date Nov. 30, 2009 [9] Nov. 30, 2009 [9] Nov. 30, 2009 [6] Nov. 30, 2009 [6]
Shares | shares 1,490,700 [9] 1,490,700 [9] 227,013 227,013
Medical Devices & Equipment | Gelesis Inc One [Member] | Equity | Preferred Series A-1        
Investment Holdings [Line Items]        
Investment cost [1]     $ 503  
Total investments at fair value     $ 3,593  
Acquisition Date [6]     Dec. 30, 2011 Dec. 30, 2011
Shares | shares     243,432 243,432
Medical Devices & Equipment | Gelesis Inc Two [Member] | Equity | Preferred Series A-2        
Investment Holdings [Line Items]        
Investment cost [1]     $ 500  
Total investments at fair value     $ 2,828  
Acquisition Date [6]     Dec. 31, 2011 Dec. 31, 2011
Shares | shares     191,626 191,626
Medical Devices & Equipment | Medrobotics Corporation [Member] | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     $ 905  
Total investments at fair value     $ 0  
Shares | shares     374,703 374,703
Medical Devices & Equipment | Medrobotics Corporation [Member] | Equity | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost [1]     $ 250  
Total investments at fair value     $ 0  
Acquisition Date [6]     Sep. 12, 2013 Sep. 12, 2013
Shares | shares     136,798 136,798
Medical Devices & Equipment | Medrobotics Corporation [Member] | Warrant Investment | Preferred Series E        
Investment Holdings [Line Items]        
Investment cost [1]     $ 370  
Total investments at fair value     $ 0  
Shares | shares     455,539 455,539
Medical Devices & Equipment | Medrobotics Corporation One [Member] | Equity | Preferred Series F        
Investment Holdings [Line Items]        
Investment cost [1]     $ 155  
Total investments at fair value     $ 0  
Acquisition Date [6]     Oct. 22, 2014 Oct. 22, 2014
Shares | shares     73,971 73,971
Medical Devices & Equipment | Medrobotics Corporation Two [Member] | Equity | Preferred Series G        
Investment Holdings [Line Items]        
Investment cost [1]     $ 500  
Total investments at fair value     $ 0  
Acquisition Date [6]     Oct. 16, 2015 Oct. 16, 2015
Shares | shares     163,934 163,934
Medical Devices & Equipment | View Ray Inc [Member] | Equity        
Investment Holdings [Line Items]        
Investment cost [1]     $ 3,991  
Medical Devices & Equipment | View Ray Inc [Member] | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 333 [2],[9]   333 [1],[6]  
Total investments at fair value $ 163 [9]   $ 201 [6]  
Acquisition Date Dec. 16, 2013 [9] Dec. 16, 2013 [9] Dec. 16, 2013 [6] Dec. 16, 2013 [6]
Shares | shares 36,457 [9] 36,457 [9] 36,457 [6] 36,457 [6]
Investment Funds And Vehicles        
Investment Holdings [Line Items]        
Investment cost [2] $ 3,499      
Total investments at fair value 3,893      
Sustainable And Renewable Technology        
Investment Holdings [Line Items]        
Total investments at fair value 15,486   $ 39,387  
Sustainable And Renewable Technology | Senior Secured Debt        
Investment Holdings [Line Items]        
Investment cost [2] 7,222      
Total investments at fair value 7,014      
Sustainable And Renewable Technology | Debt Investments        
Investment Holdings [Line Items]        
Investment cost [1]     27,159  
Total investments at fair value     27,125  
Sustainable And Renewable Technology | Equity        
Investment Holdings [Line Items]        
Investment cost 11,508 [2]   12,412  
Total investments at fair value 7,984   11,228  
Sustainable And Renewable Technology | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost 723 [2]   950 [1]  
Total investments at fair value 488   1,034  
Sustainable And Renewable Technology | Polyera Corporation | Warrant Investment | Preferred Series C        
Investment Holdings [Line Items]        
Investment cost 269 [2]   338 [1]  
Total investments at fair value   $ 0  
Acquisition Date Mar. 24, 2015 [9] Mar. 24, 2015 [9] Dec. 11, 2012 [6] Dec. 11, 2012 [6]
Shares | shares 150,036 150,036 311,609 311,609
Sustainable And Renewable Technology | Pivot Bio, Inc. | Equity | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost $ 4,500 [2]   $ 4,500 [1]  
Total investments at fair value $ 2,456   $ 3,164  
Acquisition Date Jun. 28, 2021 [9] Jun. 28, 2021 [9] Jun. 28, 2021 [6] Jun. 28, 2021 [6]
Shares | shares 593,080 593,080 593,080 593,080
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment        
Investment Holdings [Line Items]        
Investment cost $ 218 [2]   $ 218 [1]  
Total investments at fair value $ 169   $ 335  
Shares | shares 456,883 456,883 456,883 456,883
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment | Preferred Series A        
Investment Holdings [Line Items]        
Investment cost $ 155 [2]   $ 155 [1]  
Total investments at fair value $ 126   $ 249  
Acquisition Date Apr. 22, 2014 [9] Apr. 22, 2014 [9] Apr. 22, 2014 [6] Apr. 22, 2014 [6]
Shares | shares 325,000 325,000 325,000 325,000
Sustainable And Renewable Technology | Halio Inc P K Kinestral Technologies Inc | Warrant Investment | Preferred Series B        
Investment Holdings [Line Items]        
Investment cost $ 63 [2]   $ 63 [1]  
Total investments at fair value $ 43   $ 86  
Acquisition Date Apr. 07, 2015 [9] Apr. 07, 2015 [9] Apr. 07, 2015 [6] Apr. 07, 2015 [6]
Shares | shares 131,883 131,883 131,883 131,883
Sustainable And Renewable Technology | Fulcrum Bioenergy Inc | Equity | Preferred Series C-1        
Investment Holdings [Line Items]        
Investment cost [2] $ 711      
Total investments at fair value $ 995      
Acquisition Date [9] Sep. 13, 2012 Sep. 13, 2012    
Shares | shares 187,265 187,265    
Sustainable And Renewable Technology | Fulcrum Bioenergy Inc | Warrant Investment | Preferred Series C-1        
Investment Holdings [Line Items]        
Investment cost $ 64 [2]   $ 274 [1]  
Total investments at fair value $ 275   $ 699  
Acquisition Date Apr. 30, 2013 [9] Apr. 30, 2013 [9] Sep. 13, 2012 [6] Sep. 13, 2012 [6]
Shares | shares 93,632 93,632 280,897 280,897
Sustainable And Renewable Technology | Agrivida Inc | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [1]     $ 120  
Total investments at fair value     $ 0  
Acquisition Date [6]     Jun. 20, 2013 Jun. 20, 2013
Shares | shares     471,327 471,327
Sustainable And Renewable Technology | Proterra, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 542 [2],[9]   $ 543 [1],[6]  
Total investments at fair value $ 1,726 [9]   $ 4,043 [6]  
Acquisition Date May 28, 2015 [9] May 28, 2015 [9] May 28, 2015 [6] May 28, 2015 [6]
Shares | shares 457,841 [9] 457,841 [9] 457,841 [6] 457,841 [6]
Sustainable And Renewable Technology | NantEnergy, LLC | Equity | Common Units        
Investment Holdings [Line Items]        
Investment cost $ 102 [2]   $ 102 [1]  
Total investments at fair value   $ 0  
Acquisition Date Aug. 31, 2013 [9] Aug. 31, 2013 [9] Aug. 31, 2013 [6] Aug. 31, 2013 [6]
Shares | shares 59,665 59,665 59,665 59,665
Sustainable And Renewable Technology | Modumetal, Inc. | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost $ 500 [2]   $ 500 [1]  
Total investments at fair value   $ 0  
Acquisition Date Jun. 01, 2015 [9] Jun. 01, 2015 [9] Jun. 01, 2015 [6] Jun. 01, 2015 [6]
Shares | shares 1,035 1,035 1,035 1,035
Sustainable And Renewable Technology | IngredientWerks Holdings, Inc | Warrant Investment | Preferred Series D        
Investment Holdings [Line Items]        
Investment cost [2] $ 120      
Total investments at fair value      
Acquisition Date [9] Jun. 20, 2013 Jun. 20, 2013    
Shares | shares 471,327 471,327    
Sustainable And Renewable Technology | Impossible Foods, Inc. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2022-07 2022-07
Investment Interest Rate Floor [12]     8.95% 8.95%
Principal Amount [32]     $ 15,022  
Investment cost [1],[32]     19,379  
Total investments at fair value [32]     $ 19,378  
Sustainable And Renewable Technology | Impossible Foods, Inc. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [12]     9.00% 9.00%
Sustainable And Renewable Technology | Impossible Foods, Inc. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [12]     3.95% 3.95%
Sustainable And Renewable Technology | Impossible Foods, Inc. | Equity | Series E One Preferred Stock        
Investment Holdings [Line Items]        
Investment cost $ 2,000 [2]   $ 2,000 [1]  
Total investments at fair value $ 2,173   $ 3,430  
Acquisition Date May 10, 2019 [9] May 10, 2019 [9] May 10, 2019 [6] May 10, 2019 [6]
Shares | shares 188,611 188,611 188,611 188,611
Sustainable And Renewable Technology | Pineapple Energy LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2024-12 2024-12 2022-01 2022-01
Investment Interest Rate Paid in Kind [7] 10.00% 10.00%    
Principal Amount $ 3,237 [11]   $ 280 [3],[30],[35]  
Investment Interest Rate Paid in Cash [12]     10.00% 10.00%
Investment cost 3,237 [2],[11]   $ 280 [1],[3],[30],[35]  
Total investments at fair value 3,006 [11]   247 [3],[30],[35]  
Sustainable And Renewable Technology | Pineapple Energy LLC | Equity | Class A Units        
Investment Holdings [Line Items]        
Investment cost [1],[35]     4,767  
Total investments at fair value [35]     $ 591  
Acquisition Date [6]     Dec. 10, 2020 Dec. 10, 2020
Shares | shares [35]     3,000,000 3,000,000
Sustainable And Renewable Technology | Pineapple Energy LLC | Equity | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2],[9],[38] 3,153      
Total investments at fair value [9],[38] $ 634      
Acquisition Date [9] Dec. 10, 2020 Dec. 10, 2020    
Shares | shares [9],[38] 304,486 304,486    
Sustainable And Renewable Technology | Pineapple Energy LLC | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date     2023-12 2023-12
Investment Interest Rate Paid in Kind [12]     10.00% 10.00%
Principal Amount [3],[20],[35],[37]     $ 7,500  
Investment cost [1],[3],[20],[35],[37]     7,500  
Total investments at fair value [3],[20],[35],[37]     $ 7,500  
Sustainable And Renewable Technology | Ampion, PBC. | Senior Secured Debt        
Investment Holdings [Line Items]        
Maturity Date 2025-05 2025-05    
Investment Interest Rate Floor [7] 7.95% 7.95%    
Investment Interest Rate Paid in Kind [7] 1.45% 1.45%    
Principal Amount [11],[17] $ 4,037      
Investment cost [2],[11],[17] 3,985      
Total investments at fair value [11],[17] $ 4,008      
Sustainable And Renewable Technology | Ampion, PBC. | Senior Secured Debt | Exit Fee Interest Income        
Investment Holdings [Line Items]        
Interest Rate and Floor [7] 3.95% 3.95%    
Sustainable And Renewable Technology | Ampion, PBC. | Senior Secured Debt | Prime Rate        
Investment Holdings [Line Items]        
Investment Basis Spread Variable Rate [7] 4.70% 4.70%    
Sustainable And Renewable Technology | Ampion, PBC. | Warrant Investment | Common Stock        
Investment Holdings [Line Items]        
Investment cost [2] $ 52      
Total investments at fair value $ 44      
Acquisition Date [9] Apr. 15, 2022 Apr. 15, 2022    
Shares | shares 18,472 18,472    
[1] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $121.0 million, $75.7
million, and $
45.3 million, respectively. The tax cost of investments is $2.4 billion.
[2] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $72.2 million, $112.0 million, and $39.8 million, respectively. The tax cost of investments is $3.0 billion.
[3] Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2021. Refer to “Note 11 —
Commitments and Contingencies”.
[4] Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.
[5] Non-U.S. company or the company’s principal place of business is outside the United States.
[6] Except for warrants in 26 publicly traded companies and common stock in 36 publicly traded companies, all investments are restricted as of December 31, 2021
and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s Board.
[7] Interest rate PRIME represents 7.50% as of December 31, 2022. 1-month LIBOR, 3-month LIBOR, and 6-month LIBOR represent 4.40%, 4.77%, and 5.14%, respectively, as of December 31, 2022.
[8] Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2022 (Refer to “Note 11 — Commitments and Contingencies”).
[9] Except for warrants in 27 publicly traded companies and common stock in 43 publicly traded companies, all investments are restricted as of December 31, 2022 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”).
[10] Denotes second lien senior secured debt.
[11] Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments.
[12] Interest rate PRIME represents 3.25% as of December 31, 2021. 1-month LIBOR, 3-month LIBOR, and 6-month LIBOR represent, 0.14%, 0.24%, and 0.26%,
respectively, as of December 31, 2021.
[13] Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”).
[14] Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition.
[15] Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”).
[16] Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition.
[17] Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”).
[18] Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”).
[19] Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2022.
[20] Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments.
[21] Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of
December 31, 2021.
[22] Denotes second lien senior secured debt.
[23] Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.
[24] Non-U.S. company or the company’s principal place of business is outside the United States.
[25] Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company.
[26] Denotes that all or a portion of the debt investment is convertible debt.
[27] Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board.
[28] Debt is on non-accrual status as of December 31, 2022, and is therefore considered non-income producing. Note that as of December 31, 2022, only the PIK, or payment-in-kind, portion is on non-accrual for the Company’s debt investment in Tectura Corporation.
[29] Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board.
[30] Denotes that all or a portion of the debt investment is convertible debt.
[31] Denotes that all or a portion of the investment in this portfolio company is held by HC IV, the Company’s wholly owned SBIC subsidiary.
[32] Denotes that all or a portion of the investment is pledged as collateral under the Union Bank Facility (as defined in “Note 5 — Debt”).
[33] Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $4.6 million and $3.4 million, respectively.
[34] Denotes all or a portion of the public equity or warrant investment was acquired in a transaction exempt from registration under the Securities Act of 1933
(“Securities Act”) and may be deemed to be “restricted securities” under the Securities Act.
[35] Affiliate investment as defined under the 1940 Act in which Hercules owns at least 5% but generally less than 25% of the company’s voting securities.
[36] Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of
Common Stock in portfolio company Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2021,
the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $
3.0 million.
[37] Debt is on non-accrual status as of December 31, 2021, and is therefore considered non-income producing. Note that only the PIK portion is on non-accrual for the Company’s debt investment in Tectura Corporation and Pineapple Energy LLC.
[38] Denotes all or a portion of the public equity or warrant investment was acquired in a transaction exempt from registration under the Securities Act of 1933 (“Securities Act”) and may be deemed to be “restricted securities” under the Securities Act.
[39] Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2022, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $3.0 million.